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Glossary: 
Antibiotic: First coined in 1941 by Selman Waksman, the term is derived from the Greek “anti-life” 
or "opposing life, in this case of pertaining to the life of microbes. 
Argyria: This is a rare, irreversible skin condition that tends to occur after an ingestion of silver 
salts or other preparations containing silver over a prolonged period of time. 
Bactericide: A substance that kills bacteria directly. 
Biofilms: Group of microorganisms growing together and then sticking to the host cells or surface 
accompanied by a matrix of extracellular material. 
Colloid: A mixture of two or more dispersed insoluble particles. 
Drug resistance: The reduction in effectiveness of an antimicrobial in curing infections due to a 
reduced susceptibility of the target microorganism. Resistance is predominantly a consequence of 
widespread overuse of antibiotics. This has led to a global threat to human health which is 
compounded by the scarcity of new antibiotics in the clinical pipeline. 
Inflammation: A localized response elicited by endogenous danger signals, exogenous pathogen 
associated signals, injury or other destruction of cells, tissues, or organs.  In the context of infection, 
an inflammatory response by a host serves to destroy the injurious agent, however chronic or 
extreme inflammation can be deleterious to the host. 
MIC: Minimum inhibitory concentration, the lowest concentration of a substance that prevents the 
visible growth of bacteria. 
ROS: Reactive oxygen species are chemically reactive substances containing oxygen. 
Synergy: An effect produced by combining two agents wherein the result is greater than that 
observed for sum of the results elicited by the individual components.  
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Abstract 
Silver was widely used in medicine to treat bacterial infections in the 19th and early 20th 
century, up until the discovery and development of the first modern antibiotics in the 1940s, 
which were markedly more effective. Since then, every new antibiotic introduced to the clinic 
has led to an associated development of drug resistance. Today, the threat of extensive 
bacterial resistance to antibiotics has reignited interest in alternative strategies to treat 
infectious diseases, with silver regaining well-deserved renewed attention. Silver ions are 
highly disruptive to bacterial integrity and biochemical function, with comparatively minimal 
toxicity to mammalian cells. This review focuses on the antimicrobial properties of silver and 
their use in synergistic combination therapy with traditional antibiotic drugs.  
Keywords: 
antimicrobial activity, drug-resistance, silver nanoparticles, synergism 
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1. The History of Medicinal Silver 
Silver is one of the ‘noble metals’ with symbol Ag derived from the Latin word argentum. 
Argentina, a country of South America with an abundance of silver, was indeed named after 
this valuable mineral(Calvert P.A.R. 2017). The precious metal has been used in currencies, 
jewelry, decorative objects, kitchen utensils, and medicinally. Prior to the 21st century, silver 
was utilized for its antimicrobial properties in mainly domesticated forms such as needles, 
vessels, plates, cutleries, and even crude silver fillings (Figure 1).  
The word ‘silver’ in modern day English is derived from the Anglo-Saxon word ‘siolfur’, 
denoting a shiny substance. The term “blue-blood” was used to describe members of upper-
class society, and stems from a medical condition in which the skin of a person discolors to a 
bluish-grey tinge after a significant exposure of silver, first notated by Avicenna, who treated 
diseases using silver nitrate.(Alexander 2009) The phrase arose in the Middle Ages when 
only the upper social class could afford to use silver in their everyday utensils, such as 
silverwares and cutleries. Little did they know that the silver in these implements has a 
tendency to ionize into ions that easily permeate the skin.(Griffith, Simmons et al. 2015) 
Fortuitously this skin condition found favor amongst them when the bubonic plague struck, 
as “blue-bloods” had a higher chance of survival. This coincided with the scholarly discovery 
of the antimicrobial properties of silver.(Barillo and Marx 2014) 
 
 
 
Figure 1: Exemplary applications of silver related products along the course of human history 
In China during the Han Dynasty ca. 1500 BC fine acupuncture needles were crafted from silver.(Morones-
Ramirez, Winkler et al. 2013) 300 years later (ca. 1300 BC), Phoenicians preserved liquids in clay jars lined with 
silver.(Cunliffe 2011) The Macedonians applied silver plates on wounds to prevent infections in ca. 800 
BC.(Barillo and Marx 2014) Around 536 BC by Persian King Cyrus and around 335 BC by Alexander the Great, 
silver vessels were used to store drinking water during military campaigns. (Meurant 1994, Alexander 2009) 
Hippocrates (400 BC) used silver in powder form to treat ulcers and other infectious diseases.(Dai, Huang et al. 
2010) The Romans introduced silver nitrate into the contemporary Roman pharmacopoeia ca. 69 BC.(Calvery, 
Lightbody et al. 1941) During the Middle Ages, wealthy Europeans used household cutlery and dinnerware 
made out of silver (500-1500 AD).(Cunliffe 2011) Around 920 AD, Avicenna (a Persian scholar and writer) 
introduced silver fillings to treat various diseases from bad breath to irregular heartbeats and even to purify 
blood.(Wadhera and Fung 2005) Paracelsus, a Renaissance alchemist, used silver nitrate salt as caustic to treat 
wounds in 1520. While around 1614, Angelo Sala (Italian physician and chemist) ingested silver nitrate 
solutions as laxative and for the treatment of brain infections.(Hill and Pillsbury 1939) A new treatment for 
vesico-vagina fistulas was reported by Dr. Marrion J. Sims, an American physician,  in 1852. Dr. Albert Coombs 
Barnes, an American physician and Dr. Herman Hille, a German Chemist, patented Argyrol as an over-the-
counter drug in 1950.(Hodson and Gillies 1985) 
Silver as a medicinal component was almost forgotten after the discovery of modern day 
antibiotics. Antibiotics were initially considered as a wonder drug, but the potential for 
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bacteria to evade their effects by developing resistance was recognized by Fleming even 
before penicillin was widely used.(Davies and Davies 2010) Nowadays silver is being 
reconsidered as a potent antimicrobial agent with new inventions and new technologies 
derived from silver in various stages of development. In the modern era, the antimicrobial 
properties of silver have been exploited in a more sophisticated manner that is targeted to 
the treatment of diseases, using refined silver salts, colloidal silver, and especially silver 
nanoparticles.  
A search of US patents from 2000-2017 show various commercialized fields of application of 
silver nanoparticles due to their antimicrobial properties. Innovative technologies utilizing 
silver for its antimicrobial properties that have been patented cover multiple areas, such as: 
domestic cleaning products enhanced with antimicrobial silver,(Miner and Eatough 25 Dec. 
2007) antimicrobial surface coatings (potentially for food or medical devices),(Nabutovsky, 
Bornzin et al. 11 Feb. 2014, Hunt, Harris et al. 28 Jan. 2010), washable keyboards with an 
antimicrobial silver ion surface,(Whitchurch, Vaillancourt et al. 22 Oct. 2009) refrigerators 
with antimicrobial surfaces for better food preservation,(Kim 24 Aug. 2010) washing 
machines with colloidal silver,(Lee 21 Feb. 2011) wound dressings containing antimicrobial 
silver for scarring improvement,(Ma and Yu 9 Dec. 2008) antimicrobial food 
packaging,(Glenn, Vogt et al. 16 Aug. 2007, Schiffmann and Schlösser 29 Mar. 2011), silver 
odor eliminating air purifiers,(Bae, Lee et al. 8 May 2012, Kim and Kim 16 Aug. 2005) 
antimicrobial fabric embedded with silver nanoparticles(Tessier, Radu et al. 8 Oct. 2009, 
Rubinsky and Taylor 27 Aug. 2013) and water purification systems incorporating 
silver.(Harvey 8 Oct. 2013, King 09 Dec. 2013, Pradeep, Chaudhary et al. 24 Jul. 2014) 
Figure 2 demonstrates visually how the interest in the development and usage of silver as an 
antimicrobial agent has been steadily increasing over the last years (2000-2017). The graph 
shows a correlation between the number of published papers and patents. Within the 
published patents, a correlation between patents describing nanoparticles and those focused 
on antibacterial properties can be found. The number of patents about silver nanoparticles 
began substantially increasing after 2004, though in recent years patents mentioning ‘silver’ 
and ‘antibacterial’ have overtaken those mentioning ‘silver nanoparticles’. In the years 2014-
2016 the number of publications reporting antibacterial activity of silver was similar to the 
number of registered patents with the same terms. 
  
Figure 2: Innovative technologies utilizing silver due to antimicrobial properties 
Publications and patents that encompass the utilization of silver for antimicrobial activity published from 2000 
to 2017. The trend chart was generated with search results obtained from SciFinder® (American Chemical 
Society) searching for the phrase ‘antibacterial + silver’. This figure demonstrates how the development and 
usage of silver as antimicrobial agent has been steadily increasing. In 2000, less than two hundred patented 
applications were based on the concept, but by 2017 the number rose to almost 1500 patents incorporating the 
use of antibacterial silver products.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
2. Forms of silver and synthesis of silver nanoparticles 
Over time, many have sought to use silver related products for therapeutic treatments, 
however the distinction between different forms of silver has been poorly addressed, and 
questions have arisen regarding the safety and efficacy of silver. Recent reviews summarize 
how certain forms of silver are superior to others as bactericides.(Mathur, Jha et al. 2017, 
Reshma, Syama et al. 2017) Table 1 outlines different forms of silver and their associated 
products that are used for medical and healthcare purposes. Silver nanoparticles by 
themselves cover distinct forms such as metallic nanoparticles and silver oxides (Ag2O). For 
silver oxides and silver salts to be bactericidal, they first must disintegrate into silver ions. 
An enhancement of the antimicrobial activity of ionic silver has been described by using 
silver oxynitrate (Ag7NO11), where highly oxidized silver is stabilized with oxygen.(Kalan, 
Pepin et al. 2017) In this publication, the combination of non-toxic silver oxynitrate and 
commercially available wound dressings was reported to release silver ions and to disrupt 
biofilm formed from multidrug-resistant pathogens (blaNDM-1-positive Klebsiella 
pneumoniae and blaVIM-1-positive Pseudomonas aeruginosa).(Kalan, Pepin et al. 2017) 
Silver diamine fluoride is a promising drug to treat or prevent the development of caries, 
evaluated in over 20 clinical studies, with the fluoride penetrating deeper into the tooth 
compared to other fluorides.(Fung, Duangthip et al. 2017, Mei, Nudelman et al. 2017, Burgess 
and Vaghela 2018, Horst 2018) As well as dental caries, silver diamine fluoride can relieve 
dentinal hypersensitivity. It is cleared by the U.S. FDA as a medicament and has been 
commercially available in several countries for many decades.(Fung, Duangthip et al. 2017, 
Mei, Nudelman et al. 2017) 
There are various examples (see Table 1) where the combination of bioactive drug-loaded 
silver nanoparticles increases the efficacy of wound healing treatments(Berthet, Gauthier et 
al. 2017), for example by employing crystalline silver or silver sulfate.(Kee, Stockton et al. 
2017) Silver sulfate can be employed as a component in wound dressings to help kill bacteria 
and speed up the healing process, and therefore it is used in commercial products sold by 
global companies.(Kee, Stockton et al. 2017) Cysteine-modified molybdenum disulfide infused 
with silver ions and then coated with a cationic polyelectrolyte could be an alternative antibacterial 
depot suitable for treating wound infections.(Cao, Ju et al. 2017) Other wound dressings rely on 
the combination of the antibacterial properties of metals with natural or synthetic polymers 
such as polysaccharides.(Naseri-Nosar and Ziora 2018) Examples are cotton cellulosic films 
impregnated with silver nanoparticles(Pannerselvam, Jothinathan et al. 2017), formulations 
of silver sulfadiazine and bacterial cellulose,(Shao, Liu et al. 2016), or the combination of 
silver sulfadiazine with poly (ethylene glycol) hydrogels to control infections in burnt 
wounds.(McMahon, Kennedy et al. 2016) The combination of silver nanoparticles with 
keratin leads to an material with antibacterial activity against wound 
bacteria,(Shanmugasundaram and Ramkumar 2018), while the combination with cellulose 
leads to an antifouling material(Adepu and Khandelwal 2018), and chitin-silver 
nanocomposites were active against bacteria and fungi.(Solairaj and Rameshthangam 2017) 
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Silver nanoparticles are quite often in wound healing design as antiseptics to accelerate the 
recovery processes. Hydrogels with sericin-, chitosan-capped silver nanoparticles are 
proposed for reduction of the bacterial infection risk during the healing progress.(Verma, 
Kanoujia et al. 2017) Silver complexes containing silver(1) have been tested for their 
antimicrobial activity, such as silver N-heterocyclic carbene complexes that are toxic to 
bacteria while being non-hazardous towards red blood cells at similar concentrations(Aher, 
Das et al. 2017). Silver imidazolidine-2-thiones complexes have also shown bactericidal 
activity against K. pneumoniae, S. typhimurium, S. aureus and MRSA  with MICs up to 5 µg/mL, 
one yeast, C albicans. The dinuclear complexes were found to be more active than the mono-
nuclear analogues.(Aulakh, Lobana et al. 2018)  
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Table 1: Systematic tabulation of major silver derived products used for its antimicrobial properties. 
Chemical Structure Description / Application Ref. 
Pure metallic silver 
Native silver 
(Ag0) 
 
 Biologically inert form, but eventually 
dissipates into silver ions 
 Mainly used in crafting of jewelry, 
cutleries, coinage, medical equipment 
(Alexander 
2009) 
Silver salt compounds 
Silver halides  
(AgCl, AgBr, 
AgI, Ag2F, AgF, 
AgF2) 
 
 Photosensitive 
 Commonly used in photographic films 
 Used in traditional clinical X-rays 
(Aubert-
Viard, Martin 
et al. 2015, 
Vosmanská, 
Kolářová et al. 
2015) 
Silver nitrate 3AgNO  
 Widely used in history to prevent and 
cure various diseases 
 Also, used as cauterizing agent 
(Alexander 
2009, 
Barbasz, 
Kreczmer et 
al. 2016) 
Silver sulfate 2 4Ag SO  
 Is a major component in “Mepilex 
Border Ag”, a silver wound dressing 
produced by global Swedish company 
MÖLNLYCKE 
 potent antimicrobial activity killing a 
wide range of bacteria within 30 
minutes 
(Kee, Stockton 
et al. 2017) 
Silver complexes 
Silver diamine 
fluoride 3 2
AgF(NH )  
 Silver diamine fluoride as a topical 
medicament for the treatment and 
prevention of dental caries and to 
relieve dentinal hypersensitivity  
 Known as Saforide, Advantage Arrest, 
Cariesop, Bioride, FluoroplatV, Riva 
Star 
 Commercially available in many 
countries including China, Japan, 
Germany, Nepal, Brazil, Argentina, 
New Zealand, Australia and others for 
many decades  
 Cleared for sale by the U.S. FDA as a 
class II medical device for the 
treatment of dentinal hypersensitivity  
(Fung, 
Duangthip et 
al. 2017, Mei, 
Nudelman et 
al. 2017, 
Burgess and 
Vaghela 2018, 
Horst 2018) 
Silver 
sulfadiazine 
(C10H9AgN4O2S) 
 
 Largely formulated as ointments and 
creams for infection control in burnt 
wounds 
(Shao, Liu et 
al. 2015, 
McMahon, 
Kennedy et al. 
2016) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Silver zeolite 
 
 Porous mesh of sodium 
aluminosilicate containing silver ions 
 Slow release of bactericidal silver ion. 
 Potential dental material 
(Belkhair, 
Kinninmonth 
et al. 2015, 
Singh, Park et 
al. 2015) 
Silver protein 
complex  
 
 8% silver with albumin(protargol®) 
 Used to stain carbohydrates and 
nerve tissues in microscopy 
 Initial treatment for gonorrhea in 
1897 
(Sacco, Sechi 
et al. 2016) 
Silver- 
N - heterocyclic 
carbene 
complexes 
 
 Screening of silver complexes 
incorporating morpholine against S. 
aureus (MIC up to 6.25 µM), 
Salmonella enterica (MIC 50 µM) 
 Non-hazardous towards red blood 
cells at concentrations below 1.56 µM 
(Aher, Das et 
al. 2017) 
Silver 
imidazolidine-
2-thiones 
complexes 
 
 Series of silver(I)-complexes studied 
against S. aureus (MRSA), K. 
pneumoniae, Salmonella typhimurium, 
Candida albicans 
 Low cellular toxicity with high cell 
viability 
(Aulakh, 
Lobana et al. 
2018) 
Silver nanoparticles 
Metallic 
nanoparticles 
(Ag0) 
 
 Comes in few shapes such as rods, 
spheres, and dendrites in size of 1-
50 nm 
 Has different production methods 
(refer to section 3) 
 Vast applications in pathogenic 
infection control 
 Acticoat, a Smith and Nephew 
product, as one example of 
nanocrystalline silver, increasing rate 
of healing in wounds and burns by 
decreasing inflammation, maintaining 
moist, decreasing wound surface and 
reducing frequent dressing changes 
(Shenashen, 
El‐Safty et al. 
2014, Franci, 
Falanga et al. 
2015, Le Ouay 
and Stellacci 
2015, Kee, 
Stockton et al. 
2017) 
Silver oxide 
nanoparticles 
(Ag2O) 
 
 Usually found with silver colloids 
 Used widely to coat surfaces which 
need antimicrobial properties 
(Karunakaran, 
Jagathambal 
et al. 2016) 
Monoatomic 
silver ion 
(Ag+) 
 
 Easily forms bonds and complexes 
which inactivate the bactericidal 
action by oxidative stress and cell wall 
perforations, microbe metabolism 
turbulence, and DNA disruption have 
also been observed 
 All forms of silver that disintegrate 
into this form proven to be 
bactericidal 
(Jung, Koo et 
al. 2008) 
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2.1. Silver nanoparticles – their chemical and physical synthesis pathways 
 
The advantage of nanoparticles in general is their high surface to volume ratio which allows 
strong interactions at therapeutic sites and their small size facilitating penetration through 
biological membranes. Silver nanoparticles consist of a range of nanostructures and 
crystallization forms. Different synthesis methods are employed to prepare silver 
nanoparticles, leading to variations in specific nanoparticle morphology and accompanying 
physical and chemical properties, such as conductivity, thermal and melting 
point.(Chaloupka, Malam et al. 2010, Shenashen, El‐Safty et al. 2014, Wu, Yang et al. 2018) 
The morphology of crystal formation can be controlled based on the distance of crystal 
formation from the thermodynamic equilibrium.(Le Ouay and Stellacci 2015)  
In this review, recently published synthesis procedures are described with an emphasis on 
their application. A widely used method to synthesize nanoparticles is chemical reduction of 
silver ions, employing chemical reducing agents such as sodium borohydride, citrate, 
ascorbate or hydrogen. Table 2a summarizes recently reported methods of silver 
nanoparticle synthesis with an emphasis on their application.  
Silver nanoparticles synthesized by chemical reduction with sodium borohydride have been 
combined with a variety of other agents. Adenosine triphosphate coated silver nanoparticles 
have activity both against bacteria and cancer cells(Datta, Chatterjee et al. 2017), while 
cellulose fibers functionalized with silver nanoparticles and stabilized by dendrimers  
improve biocidal potency in textile products(Kebede, Imae et al. 2017). The functionalization 
of silver nanoparticles with vancomycin results in an enhancement of antimicrobial 
activity(Kaur, Goyal et al. 2017). Other antimicrobial materials were obtained by reducing 
silver nitrate with sodium borohydride in the presence of other additives, such as silver 
nanoparticles stabilized by sodium dodecyl sulfate(Schwass, Lyons et al. 2018), by cationic 
ligands(Dai, Chen et al. 2017), or by chitosan(dos Santos Junior, Targino et al. 2017). The 
products are capable of inhibiting biofilm formation and suggested to be used for the 
treatment of caries. Silver nanoparticles with keratin(Shanmugasundaram and Ramkumar 
2018), cellulose(Adepu and Khandelwal 2018) and chitin(Solairaj and Rameshthangam 
2017) were prepared using chemical reduction method with sodium borohydride (keratin 
and cellulose) or trisodium citrate (chitin) as reductants. 
Radiation can be also used for the reduction of silver salts to nanoparticles with, for example, 
gamma irradiation to form bioactive nanogels for the development of antimicrobial 
surfaces(Anjum, Patra et al. 2016) or by preparing nanosilver functionalized glass through 
photoreduction to prevent the development of oral biofilms(Paiva, Fidalgo et al. 2017). 
Furthermore, silver nitrate was reduced by electrical energy in the presence of polyethylene 
glycol and the morphology of the formed nanoparticles was controlled under various 
reaction conditions.(Nasretdinova, Fazleeva et al. 2015) Microwave energy can also reduce 
silver nitrate to induce silver nanocrystal formation.(Shenashen, El‐Safty et al. 2014) Silver 
nanoparticles could be obtained by microwave sintering, with improved antibacterial activity 
depending on the temperature.(Shi, Zhou et al. 2017) In another study, silver nitrate reduced 
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by argon glow discharge was incorporated into functionalized cotton fabrics with an 
antimicrobial activity.(Li, Meng et al. 2017)  
A thermal reduction method can be applied to embed silver nanoparticles on different 
materials by heating the reaction mixtures of silver salts and additives. Nanocomposites were 
obtained with varying properties: nanocomposites of graphene oxide and silver 
nanoparticles (heated at 60°C) were utilized to eliminate bacterial biofilms(Wang, Han et al. 
2018), activated carbon fibers (self-assembled at 98°C, followed by carbonization) showed 
an antimicrobial activity(Yan, Xu et al. 2017), nanocomposites of silver and TiO2 (heated at 
100°C, then calcined at 500°C; heated again at 180°C) exhibited a synergistic antimicrobial 
activity against Escherichia coli(Wang, Chen et al. 2017, Ye, Cheng et al. 2017) and 
Staphylococcus aureus(Ye, Cheng et al. 2017). The combination of silver nanoparticles with 
zeolite (heated at 90°C) resulted in an antibacterial material active against methicillin-
resistant S. aureus(Chen, Popovich et al. 2017), while functionalization with chitosan 
(hydrothermal method employing 140°C)(Biao, Tan et al. 2017) or the preparation of 
composite membranes with silver loaded sepiolite (heated at 150°C)(Díez, Santiago-Morales 
et al. 2017) were accompanied with an increased antibacterial activity. Nanostructured silver 
vanadates were proposed as an antimicrobial agent against a range of pathogenic bacteria or 
for dental applications.(de Melo Monteiro, Dias Holtz et al. 2018) 
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Table 2a: Recently published methods for the synthesis of silver nanoparticles with emphasis on their 
application. 
 General overview of the 
method 
Advantage Targeted application Ref. 
C
h
e
m
ic
a
l 
R
e
d
u
ct
io
n
 w
it
h
 N
a
B
H
4
 
ATP (adenosine triphosphate) 
coated silver nanoparticles were 
prepared in phosphate buffer (pH 
7.4) at 37°C with NaBH4 as a 
reducing agent 
Novel method of nucleotide 
metallization via interaction 
of silver nanoparticles with 
adenosine triphosphate 
Treatment of human cancer, 
excellent bactericidal activity 
over both Gram-positive and 
Gram-negative bacilli 
(Datta, 
Chatterjee et al. 
2017) 
Silver nanoparticles prepared 
from an aqueous AgNO3 solution 
mixed with PAMAM, NaBH4 was 
added to the reaction mixture to 
obtain dendrimer silver 
nanoparticles which were bound 
on viscose rayon fiber  
Good biocidal activity 
against E. coli 
The immobilization of 
functional metal nanoparticles 
protected by dendrimer on 
cellulose fibers as textile 
products with smart functions 
to minimize sick building 
syndromes 
(Kebede, Imae 
et al. 2017) 
Nanoparticles were synthesized 
using trisodium citrate and PVP 
as capping agents, NaBH4 as 
reducing agent and AgNO3 as 
precursor. 
Functionalized with a 
glycopeptide antibiotic 
Model system for the 
development of new 
bactericides 
(Kaur, Goyal et 
al. 2017) 
Reduction of AgNO3 with NaBH4 
in the presence of sodium dodecyl 
sulfate 
Inhibition of biofilm 
formation by Streptococcus 
spp. and Enterococcus 
faecalis in vitro 
Disinfection of carious dentine (Schwass, 
Lyons et al. 
2018) 
Reduction of AgNO3 with NaBH4, 
sodium citrate and addition of 
NH3·H2O and NaOH in water  
Size-tuneable nanoparticles 
with highly uniform 
morphologies and narrow 
size distributions  
Antibacterial activity, against E. 
coli and S. aureus 
(Wu, Yang et al. 
2018) 
Reduction of AgNO3 in the 
presence of trisodium citrate 
Antibacterial material by 
combining silver 
nanoparticles and keratin 
Antibacterial activity against 
burn wound bacteria 
(Shanmugasund
aram and 
Ramkumar 
2018) 
Mixing of AgNO3 with the 
described polymer and addition 
of NaBH4 
Activity against antibiotic-
resistant Gram-negative, 
Gram–positive bacteria and 
bacterial biofilms 
Therapy of pathogenic bacterial 
infections 
(Dai, Chen et al. 
2017) 
The silver-bacterial cellulose (BC) 
composites were synthesized by 
mixing AgNO3 with NaBH4 and BC 
Bacterial cellulose-based 
antifouling material 
Protection of food from 
microbial spoilage 
(Adepu and 
Khandelwal 
2018) 
AgNO3 was reduced with NaBH4, 
sodium citrate and PVP as a 
stabilizing agent 
High antimicrobial activity 
and low environmental and 
cytotoxic effects  
Alternative antimicrobial 
substance against fish 
pathogens, novel therapeutics 
in aquacultures 
(Shaalan, El-
Mahdy et al. 
2017) 
Addition of AgNO3 to a chitosan 
solution in acetic acid, followed 
by addition of NaBH4 
Size and shape of the 
nanoparticles had no 
influence on the 
antimicrobial properties 
against Streptococcus 
mutans 
Treatment of caries (dos Santos 
Junior, Targino 
et al. 2017) 
R
e
d
u
ct
io
n
 u
si
n
g
 
ra
d
ia
ti
o
n
 
Nanosilver embedded 
polyacrylamide nanogels were 
synthesized using AgNO3 in a 
gamma irradiation process 
Bioactive nanogels with 
antimicrobial potency 
against E. coli and S. aureus 
Development of antimicrobial 
surfaces in surgical devices and 
synthetic implants 
(Anjum, Patra 
et al. 2016) 
Photoreduction of silver 
nanoparticles in a polyacrylate 
solution 
 
Production of nanosilver 
glass ionomer cements with 
an antibacterial effect by 
diffusion 
Dental application by 
preventing the development of 
oral biofilms 
(Paiva, Fidalgo 
et al. 2017) 
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T
h
e
rm
a
l 
re
d
u
ct
io
n
 m
e
th
o
d
 
Silver nanoparticles were 
synthesized on graphene oxide 
nanosheets in the presence of 
poly (vinyl pyrrolidone) at 60°C 
Nanocomposites of 
graphene oxide with silver 
chloride/silver with high 
visible light absorption and 
antibacterial properties 
Elimination of bacterial 
biofilms under visible light 
irradiation for applications as 
wound dressing or water 
purification 
(Wang, Han et 
al. 2018) 
HBPAA-capped silver 
nanoparticles were self-
assembled on viscose fibers at 
98°C, followed by peroxidation 
and carbonization 
Activated carbon fibers 
functionalized with silver 
nanohair with durable 
antibacterial activity 
Activated carbon fibers with 
antibacterial activity 
(Yan, Xu et al. 
2017) 
Ag/titanium glycolate particles 
were heated at 100°C, then 
calcined to 500°C 
Macroporous Ag/TiO2 
composite foams with 
synergistic antimicrobial 
activity against E. coli 
Material with bactericidal 
activity 
(Wang, Chen et 
al. 2017) 
Synthesis of Ag/carbon spheres 
using AgNO3, CTAB, glucose at a 
temperature of 180°C. The 
TiO2/Ag composite was obtained 
employing the spheres in the 
presence of tetrabutyl titanate at 
180°C 
Spherical titanium 
dioxide/silver composite 
showing synergistic effects 
against E. coli and S. aureus 
with a bacteriostatic rate up 
to 99% 
Durable antimicrobial coating 
for application in bacterial 
sensitive locations 
(Ye, Cheng et al. 
2017) 
The glass preservative was mixed 
with silver oxide and other 
materials and melted at 950°C 
Inorganic UV filter 
incorporating TiO2, Ag and 
ZnO 
Integration into polymers, UV 
screen textiles or coatings 
(de Lucas-Gil, 
Rubio-Marcos 
et al. 2016) 
Preparation of thin films by 
multi-magnetron sputtering 
Coatings based on titanium 
and silver with a biocidal 
effect 
Nanocrystalline films as 
antimicrobial coatings 
(Wojcieszak, 
Mazur et al. 
2017) 
Combination of zeolite 
suspension with dissolved AgNO3 
at 90°C 
Silver-ion-exchanged 
nanostructured zeolite with 
antimicrobial activity 
against methicillin-resistant 
S. aureus 
Antibacterial material based on 
nanostructured zeolite 
(Chen, Popovich 
et al. 2017) 
Synthesis of silver colloid using a 
hydrothermal method (140°C) 
with chitosan both as reductant 
and stabilizer 
Chitosan-functionalized 
silver nanoparticles with 
bactericidal effect against 
bacteria and fungus 
Potential bactericidal agent (Biao, Tan et al. 
2017) 
Nanoparticles obtained at 150°C   Membranes with metal 
loaded sepiolite showing 
antibacterial activity 
Composite membranes with 
silver as antibacterial activity 
(Díez, Santiago-
Morales et al. 
2017) 
Nanosilver oxide synthesis with 
PVA, PVP, chitosan and AgNO3 
and calcination at 600°C 
Suppression of gastric 
inflammation and inhibition 
of oxidative stress  
Antiulcerogenic potential of 
nanosilver oxide for the 
prevention of gastric ulcers 
(Salem, Wahba 
et al. 2017) 
Reaction of AgNO3 with 
carboxymethyl functionalized 
cellulose in the presence of citric 
acid at 95°C 
Combination of non-toxicity 
with antibacterial activity 
against S. aureus, E. coli, P, 
aeruginosa 
Nanocomposites incorporated 
in hydrogel membranes for skin 
wound dressings or skin repair 
substitutes 
(Capanema, 
Mansur et al. 
2018) 
O
th
e
r 
re
d
u
ct
io
n
 m
e
th
o
d
s 
Reduction of AgNO3 with 
polyaniline-coated or 
polypyrrole-coated fabrics 
Coated cotton fabric with 
silver nanoparticles with 
good antibacterial activity 
against S. aureus and E. coli 
These cotton fabrics coated 
with conducting polymers 
could be applicable for the 
potential electrostimulation 
(Maráková, 
Humpolíček et 
al. 2017) 
Ca(NO3)2 hydrate, AgNO3 and 
(NH4)2HPO4 reacted together 
followed by conventional and 
microwave sintering 
Higher antimicrobial 
activity of particles sintered 
by microwave 
Improved antibacterial activity 
with increase of temperature 
(Shi, Zhou et al. 
2017) 
AgNO3 reduced by chitosan and 
sericin (reducing and stabilizing 
polymer) to produce chitosan-
Accelerated wound healing 
with improved patient 
compliance 
Silver-based antiseptics, 
reduction of the risk of 
bacterial infection during the 
healing process 
(Verma, 
Kanoujia et al. 
2017) 
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and sericin-capped silver 
nanoparticle loaded hydrogels 
Formation of silver nanoparticles 
on cotton fabrics by reducing 
AgNO3 with argon glow discharge 
as the electron source 
Fabrication of silver 
nanoparticles on cotton 
without using any chemical 
reducing agent 
Functionalized fabrics with 
high antimicrobial activity for 
wearable devices 
(Li, Meng et al. 
2017) 
Reduction of AgNO3 with 
trisodium citrate, followed by 
addition to chitin nanoparticles 
Chitin-silver nanocomposite 
with an enhanced 
antimicrobial effect on 
bacteria and fungi  
Usage as a biocompatible 
larvicidal material 
(Solairaj and 
Rameshthanga
m 2017) 
Mixing AgNO3, chitosan-L-
glutamic acid and hyaluronic acid 
Antimicrobial activity 
against E. coli and S. aureus 
and promotion of wound 
healing 
Spongy composites used as 
antibacterial wound dressings 
(Lu, Lu et al. 
2017) 
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2.2. Silver nanoparticles – “Green” synthesis methods 
“Green” synthesis methods consider environmental issues, such as selection of less toxic 
solvents, reducing agents, and stabilizers. Over the past decade, numerous publications have 
reported variety of protocols with silver nanoparticles synthesized by a biological method 
rather than a chemical one. A comprehensive summary of all known eco-friendly methods is 
out of the scope for this review, but we summarize a variety of approaches in Table 2b. 
„Green“ synthesis routes make use of plant, wood and fruit extracts, bacteria, fungi or other 
sources. Depending on the synthesis method, the size and morphology of the produced silver 
nanoparticles vary, as do their biological properties.  
Generally, silver nitrate is used as a precursor for the bio-reduction processes with biological 
sources used as reducing agents. Some plants contain caffeine and theophylline that are 
known to act as stabilizers for silver ion formations. Numerous attempts have generated 
nanoparticles from many different types of plant components including green tea, moringa 
and henna leaves, clove and cinnamon bark extract, germanium plants, chestnut trees 
isolates, and mangosteen fruits.(Shenashen, El‐Safty et al. 2014, Rupiasih, Aher et al. 2015, 
Rajput, Raghuvanshi et al. 2017) The use of plant material to hasten the reduction process 
was successful in terms of high yields and rapid syntheses, however the downside is that 
parameters such as the size and morphology of the nanoparticle products are hard to 
control.(Shenashen, El‐Safty et al. 2014, Ahmed, hmad et al. 2016)  
Wood extracts can be used for the biosynthesis of nanoparticles, for example a Eucalyptus 
extract employed as the reductant for AgNO3.(Shivakumar, Nagashree et al. 2017) These 
synthesized nanoparticles possesed an antimicrobial activity against both bacteria and 
fungus. Bark extracts of Guazuma ulmifolia(Karthika, Arumugam et al. 2017) and Prosopis 
juliflora(Arya, Kumari et al. 2017) reduced AgNO3 at ambient temperature resulting in 
nanoparticles showing activity against several pathogens. Other plant extracts reducing 
AgNO3 in aqueous solution include leaf extracts from Erythrina suberosa rich in glycosides, 
flavonoids and phenolic compounds, and capable of reduction at room 
temperature.(Mohanta, Panda et al. 2017) Aqueous leaves extracts from Artemisia 
haussknechtii(Alavi and Karimi 2017), Bryophyllum pinnatum(Tareq, Fayzunnesa et al. 
2017), Protium serratum(Mohanta, Panda et al. 2017), Thymbra spicate(Erci, Cakir-Koc et al. 
2017) and Angelicae Pubescentis Radix root (Markus, Wang et al. 2017) all yielded silver 
nanoparticles with antimicrobial activity against food, multi-drug resistant, agriculture or 
plant pathogens.  
Fruit extracts are also described to act both as the reducing and stabilizing agent for the 
synthesis of silver nanoparticles. Reaction of Actinidia deliciosa and AgNO3 at 80°C yielded 
silver nanoparticles with antibacterial and anticancer activity.(Naraginti and Li 2017) The 
silver nanoparticles synthesized with aqueous extracts of Prunus cerasifera showed anti-
bactericidal action against several strains.(Jaffri and Ahmad 2017)  
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Fungi can be employed as silver nanoparticle secreting hosts, with an advantage of high 
yielding production of highly stable silver nanoparticles. The main mechanism works by 
trapping Ag+ in the fungal cell where multiple reduction enzymes can act on the 
ions.(Shenashen, El‐Safty et al. 2014) Mycosynthesis has been performed using cell free 
filtrates of Trichoderma viride(Kumari, Shukla et al. 2017), Penicillium chrysogenum(Sheet, 
Sathishkumar et al. 2017), Chaetomium globosum(Singh, Kumar et al. 2018) or Aspergillus 
niger plus Fusarium semitectum(Madakka, Jayaraju et al. 2018) to yield silver nanoparticles 
with activity against various bacteria or cancer cells. The supernatant of several bacterial 
strains has also been employed to reduce AgNO3, including Bacillus amyloliquefaciens and 
Bacillus subtillis(Fouad, Hongjie et al. 2017, Ghiuță, Cristea et al. 2017), Streptomyces 
xinghaiensis(Wypij, Czarnecka et al. 2018) or Novosphingobium(Du, Singh et al. 2017). The 
products showed antimicrobial activity against several pathogens. Similarly, nanoparticles 
were produced by silver resistant bacteria possessing nicotinamide adenine dinucleotide 
phosphate hydride (NADPH) and NADPH-dependent enzymes such as nitrate reductase, 
including K. pneumoniae, E. coli, E. cloacae, Aeromonas sp.SH10, Corynebacterium sp.SH09 and 
Bacillus licheniformis.(Prabhu and Poulose 2012, Shenashen, El‐Safty et al. 2014) 
Other strategies and further reducing methods for the synthesis of silver nanoparticles 
include the use of mushroom extracts of Ganoderma applamatum as a reductant for AgNO3 at 
room temperature, forming silver nanoparticles with antibacterial activity(Mohanta, 
Singdevsachan et al. 2016). Natural amino acids can act both as reducing and capping agent 
for nanoparticle synthesis.(Kumar, Bansal et al. 2018) In another approach, the combination 
of light irradiation and rice straw biomass successfully produced silver nanoparticles with 
antibacterial activity.(Li, Ma et al. 2017) Silver nanoflowers were synthesied in the presence 
of poly-dopamine copper phosphate to yield selective antibacterial agents.(Zhang, Peltier et 
al. 2017) 
“Green” synthesized silver nanoparticles have found similar application to those synthesized 
chemically or physically. They have been used in antimicrobial, anti-inflammation, or 
anticancer medical fields as wound healing accelerators, in antiseptic clothing or for other 
biomedical purposes. They are recognized as very attractive components for the food and 
agriculture sectors, and in the pharmaceutical industry, thanks to their very low toxicity and 
environmentally-friendly production.  
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Table 2b: Recently published methods for the green synthesis of silver nanoparticles with emphasis on their 
application. 
 General overview of the 
method 
Advantage Targeted 
application 
Ref. 
B
io
sy
n
th
e
si
s 
u
si
n
g
 w
o
o
d
 
e
x
tr
a
ct
s 
Synthesis using pre-hydrolysed 
liquor (generated from pulp and 
paper industries) of Eucalyptus 
wood as reductant and AgNO3 
Biosynthesized silver nanoparticles 
with antimicrobial activity against 
bacteria (P, aeruginosa, S. aureus, E. 
coli) and fungus 
Growth inhibitors for 
biomedical 
applications 
(Shivakumar, 
Nagashree et al. 
2017) 
Preparation with a bark extract of 
Guazuma ulmifolia and AgNO3 at 
room temperature 
Catalytic activity as reducing agent, 
able to bind to CT-DNA (groove-
binding mode), antimicrobial 
activity on microbial pathogens  
Bark- synthesized 
nanoparticles as 
antimicrobial, 
antifungal, anticancer 
agents 
(Karthika, 
Arumugam et al. 
2017) 
Reduction of AgNO3 using 
Prosopis juliflora bark extract at 
room temperature 
Antibacterial activity against E. coli 
and P, aeruginosa, anticancer 
activity against A549 cell line 
Antimicrobial, 
anticancer activity 
(Arya, Kumari et 
al. 2017) 
B
io
sy
n
th
e
si
s 
u
si
n
g
 p
la
n
t 
e
x
tr
a
ct
s 
Aqueous leaf extracts of Erythrina 
suberosa containing glycosides, 
flavonoids, phenolic compounds 
with AgNO3 at room temperature  
Antimicrobial activity against 
pathogenic bacteria and fungi 
Antimicrobial, 
anticancer agent and 
wound healing 
application 
(Mohanta, Panda 
et al. 2017) 
AgNO3 stirred with aqueous 
Artemisia haussknechtii leaves 
extract at room temperature 
Antibacterial activity against multi-
drug resistant bacteria (S. aureus, S. 
epidermidis, Serratia marcescens 
and E. coli) 
Antibacterial activity (Alavi and Karimi 
2017) 
Silver nanoparticle preparation 
using Bryophyllum pinnatum 
leaves extract and AgNO3 
Activity against food (E. coli) and 
agriculture (Bacillus megaterium) 
pathogens 
Application in the food 
(food safety) and 
agricultural sector 
(agricultural 
production) 
(Tareq, 
Fayzunnesa et al. 
2017) 
Reduction of AgNO3 with aqueous 
extract of roots of Angelicae 
Pubescentis Radix 
Antimicrobial activity against E. 
coli, S. aureus, P, aeruginosa, 
Salmonella enterica 
Potential application 
as drug carriers to 
inflammation-sites or 
medical imaging 
(Markus, Wang et 
al. 2017) 
Aqueous extract of Dionaea 
muscipula, D. binate, D. spatulata, 
D. indica tissue and PVP were 
used to reduce AgNO3 at 70°C 
Antibacterial activity against 
human and plant pathogens 
Antimicrobial 
properties 
(Banasiuk, 
Krychowiak et al. 
2017) 
Reaction between AgNO3 and 
leaves extract of Protium 
serratum 
Antibacterial activity against food 
borne pathogens (P, aeruginosa, E. 
coli, B. subtilis) 
Antibacterial agent in 
food packaging and 
preservation 
(Mohanta, Panda 
et al. 2017) 
Reaction between aqueous 
leavesextracts of Thymbra spicate 
and AgNO3 at room temperature  
Antibacterial activity against Gram-
negative and Gram-positive 
bacteria 
Controlling biological 
activity of the silver 
nanoparticles 
(Erci, Cakir-Koc et 
al. 2017) 
B
io
sy
n
th
e
si
s 
u
si
n
g
 f
ru
it
 e
x
tr
a
ct
s 
Actinidia deliciosa fruit extract 
(reducing and stabilizing agent) 
added to AgNO3 and reacted at 
80°C 
Antimicrobial activity (P, 
aeruginosa), anticancer activity 
(tested against human colon cancer 
HCT116 cells) 
Field of biomedicine, 
water treatment, 
nanobiotechnology 
(Naraginti and Li 
2017) 
Reduction of AgNO3 by chemical 
reduction (NaBH4) using an 
aqueous extract of pomegranate 
peel (stabilizer) 
Antibacterial activity against E. coli Antibacterial activity  (Nasiriboroumand, 
Montazer et al. 
2018) 
Synthesis of silver nanoparticles 
using aqueous fruit extract 
Prunus cerasifera (angiospermic 
plant) and AgNO3 
Antimicrobial activity against 
Xanthomonas citri, P, syringae, 
Aspergillus niger, Aspergillus flavus, 
Aspergillus fumigatus, Aspergillus 
terreus, Penicillium chrysogenum, 
Fusarium solani, Lasiodiplodia 
theobromae 
Application as 
nanobactericides and 
nanofungicides  
(Jaffri and Ahmad 
2017) 
M y
c
o
s y n
t h e
s is
 Aqueous solution of AgNO3 
reduced and modified using 
Antimicrobial activity against 
Shigella sonnei, P, aeruginosa and S. 
Pharmaceuticals and 
agriculture 
(Kumari, Shukla et 
al. 2017) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
secondary metabolites of cell free 
filtrate of Trichoderma viride at 
28°C 
aureus with enhanced 
internalization of the synthesized 
nanoparticles compared to 
particles which have been 
stabilized by citrate 
pharmaceutical 
industry 
Synthesis using culture filtrates of 
Penicillium chrysogenum and 
AgNO3 at 25°C 
 
Antimicrobial activity against E. 
coli, P, aeruginosa, S. aureus, 
Enterococcus faecalis and 
cytotoxicity against cancer cells 
Field of 
nanotechnology, 
astrobiology 
(Sheet, 
Sathishkumar et 
al. 2017) 
Aqueous AgNO3 and cell free 
filtrate of endophytic Chaetomium 
globosum  
Antimicrobial activity against S. 
aureus, K. pneumoniae 
Bactericidal activity 
for drug development 
of nanoantibiotics 
(Singh, Kumar et 
al. 2018) 
Reduction of AgNO3 with cell free 
filtrates of fungi Aspergillus niger 
and Fusarium semitectum 
Antimicrobial activity against E. 
coli, S. aureus, P, aeruginosa 
Antimicrobial agents 
for medical purposes 
(Madakka, 
Jayaraju et al. 
2018) 
B
io
sy
n
th
e
si
s 
u
si
n
g
 b
a
ct
e
ri
a
 
Reduction of AgNO3 by Bacillus 
amyloliquefaciens, B. subtillis 
(aqueous enzymatic extracts from 
cell free supernatant as reducing 
agent) at 33°C 
Antimicrobial activity against E. 
coli, P, aeruginosa, Salmonella, S. 
aureus, Streptococcus pyogenes, 
Candida albicans 
Exploiting 
antibacterial effect, 
potential in the optical 
domain (for example 
colour tuning by 
nanoparticle 
incorporation) or 
biosensor assays 
(Ghiuță, Cristea et 
al. 2017) 
Cell free supernatant of bacteria 
strains (B. amyloliquefaciens, B. 
subtilis) was used to reduce 
AgNO3 
Toxic against the larvae and pupae 
Culex Pipiens pallens 
Combination of 
bacteria silver 
nanoparticle with 
antibacterial activity 
to control vector 
mosquito and bacteria 
(Fouad, Hongjie et 
al. 2017) 
Silver nanoparticles obtained 
using supernatant of 
Streptomyces xinghaiensis and 
AgNO3 at room temperature 
Antimicrobial activity against E. 
coli, P, aeruginosa, S. aureus, B. 
subtilis, Candida albicans, 
Malassezia furfur 
Potential for 
application in 
nanomedicine  
(Wypij, Czarnecka 
et al. 2018) 
AgNO3 reduced with supernatant 
of bacterial strain 
Novosphingobium at 25°C 
Antimicrobial activity against S. 
aureus, Candida tropicalis, P, 
aeruginosa, E. coli, Vibrio 
parahaemolytics, Candida albicans, 
Salmonella enterica, B. subtilis, 
Bacillus aureus 
Antimicrobial agent 
against multidrug-
resistant bacteria 
(Du, Singh et al. 
2017) 
B
io
sy
n
th
e
si
s 
u
si
n
g
 o
th
e
r 
m
e
th
o
d
s 
Mushroom extract from 
Ganoderma applanatum was 
reacted with AgNO3 at room 
temperature 
Antibacterial activity against E. coli, 
B. subtilis, S. epidermidis, Vibrio 
cholerae, S. aureus, Shigella flexneri 
Use in medical 
devices, as 
antimicrobial agent, 
production of 
nanomedicines 
(Mohanta, 
Singdevsachan et 
al. 2016) 
AgNO3 was reduced by rice straw 
biomass at room temperature 
using light irradiation 
Antimicrobial activity against E. 
coli, P, aeruginosa, B. subtilis, S. 
aureus 
Silver nanoparticles as 
an adjuvant drug 
treatment against 
bacteria 
(Li, Ma et al. 2017) 
Combination of silver 
nanoparticles (AgNO3) and Fe3O4 
nanoparticles (FeCl3 hydrate and 
FeSO4 hydrate) using starch as 
stabilizer and capping agent to 
produce nanocomposites 
Antibacterial activity evaluated in a 
wound biofilm model 
Treatment of chronic 
wound infections 
(Ghaseminezhad, 
Shojaosadati et al. 
2017) 
Silver nanoparticles were 
prepared from AgNO3and 
curcumin (reducing and capping 
agent) 
Antibacterial and antibiofilm 
activity while being less toxic to 
human keratinocytes 
Wound dressing agent (Jaiswal and 
Mishra 2018) 
Synthesis of silver nanoparticles 
with natural α-amino acids 
(reducing and capping agent) and 
AgNO3 
Antimicrobial activity against E. 
coli, S. aureus, K. pneumoniae, P, 
aeruginosa 
Antimicrobial agents 
against drug-resistant 
strains 
(Kumar, Bansal et 
al. 2018) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Reaction of PD/copper phosphate 
nanoflowers with AgNO3 
No need of external toxic 
reductants, selective toxicity 
towards bacterial cells 
Treatment of 
infections, 
sterilization of 
surfaces 
(Zhang, Peltier et 
al. 2017) 
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3. Silver’s mechanism of action  
The precise mechanism by which silver induces bacterial cell death is still not fully 
understood.(Durán, Durán et al. 2016) Multiple studies have concluded that silver ions can 
disrupt more than one cellular process leading to its bactericidal action(Durán, Durán et al. 
2016, Mathur, Jha et al. 2017, Reshma, Syama et al. 2017) (a schematic presentation of one 
mechanism is presented as a component of Figure 3). Silver nanoparticles can dissociate to 
biologically active silver ions (Ag+) that have been shown to bind to bacterial cells walls via a 
“Trojan Horse” mechanism that then draws more silver ions into the cell.(Singh, Shedbalkar 
et al. 2015) The anchoring and penetration of silver nanoparticles to the bacterial cell wall 
results in structural changes, changing cell wall permeability. This activity,  together with the 
formation of free radicals, damages the cell membrane.(Mathur, Jha et al. 2017) Bacterial cell 
walls are comprised of peptidoglycan, a polymer composed of sugar and amino acid residues. 
The sugar molecules, namely β-(1,4) linked N-acetylglucosamine and N-acetylmuramic acid, 
are attached to a peptide chain made of three to five amino acid which cross-links to form a 
mesh around the cytoplasm. Studies have proposed that silver nanoparticles and silver ions 
can interact with this layer to form pits by destroying the cross-linking bonds.(Agnihotri, 
Mukherji et al. 2014) Pits formed in the cell wall will cause internal cell content to leak out to 
the surrounding media and cause cell disintegration.(Jung, Koo et al. 2008, Rai, Yadav et al. 
2009, Morones-Ramirez, Winkler et al. 2013, Franci, Falanga et al. 2015) 
Another proposed mechanism of action is that the presence of silver ions triggers increases 
production of hydroxyl radicals which disrupt cellular regulations. The overproduction of 
reactive oxygen species can be triggered when the metabolic pathways, which are driven by 
Fenton chemistry, are disrupted by silver ions.(Morones-Ramirez, Winkler et al. 2013) It has 
been shown that reactive oxygen species (ROS) induced by silver nanoparticles can lead to 
cell apoptosis.(Quinteros, Aristizábal et al. 2016, Saini, Saha et al. 2016, Patil and Kim 2017) 
ROS production increased under visible light irradiation by graphitic carbon nitride 
nanosheets entrenched with silver nanoparticles resulted in an enhancement of antibacterial 
efficacy.(Bing, Chen et al. 2015) Again, the bacterial cell membrane is rendered unstable and 
more permeable to the extracellular environments.(Kumari, Shukla et al. 2017) The 
interactions of silver ions with thiol groups of cellular proteins is reported to lead to poor 
protein folding.(Russell and Hugo 1994) When these misfolded proteins are localized on the 
cellular membrane, the overall membrane structure will be further weakened and more 
permeable. 
Studies propose that silver ions bind to the functional groups of key enzymes, halting cell 
division as well as cell metabolism.(Jung, Koo et al. 2008) Complexes of membrane targeting 
cationic ligands and silver nanoparticles could disrupt the membrane structure of bacteria 
(S. aureus, P, aeruginosa) resulting in an inhibition of intracellular enzyme activity.(Dai, Chen 
et al. 2017) It has also been proposed that bacteria exposed to silver ions over a long term 
basis end up with disrupted nucleic acid sequences.(Mijnendonckx, Leys et al. 2013) Silver 
ions have high tendencies to form stable complexes with nucleic acid preventing 
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transcription and stopping bacterial activity at the genetic level. The exact pathways have not 
yet been identified.(Franci, Falanga et al. 2015) 
In summary, when bacteria cells are exposed to silver, the bacterial cell wall is punctured and 
degenerated, causing the cytoplasm to leak. Upon degradation of the bacterial cell wall, the 
bacteria become more susceptible to further influx of silver ions which causes disruption of 
cellular protein production and metabolic dysfunction. Cell growth and division is ultimately 
affected due to the silver ions’ ability to cause genetic disruption and enzymatic 
inhibition.(Durán, Durán et al. 2016, Dai, Chen et al. 2017, Reshma, Syama et al. 2017) The 
activity of silver nanomaterials is dependent both on the size and the structure 
(nanoparticles, nanorods, nanofibers or nanomats).(Lu, Ye et al. 2014, Vimbela, Ngo et al. 
2017)  
 
Figure 3: Silver ions mode of action and ways for the introduction of silver into the human body 
Entry methods and the effect of silver in the human body are summarized in this figure. Furthermore, a 
schematic model of the destructive forces of silver ions towards microbes is presented in the left upper corner. 
Silver ions can inhibit the growth of the microbe by perforating and weakening the cell wall of organism (1), by 
disrupting metabolic pathways (2) or by stopping the cell replication through attaching to DNA (3).(Jung, Koo 
et al. 2008, Morones-Ramirez, Winkler et al. 2013) Entry routes include: Skin: topical application of silver 
containing medication such as silver wound dressing, contact with silver particles, or elements. Particles 
smaller than 10 nm can pass through the pores of the tough outer layer (stratum corneum). Particles around 7-
20 nm may penetrate through sweat and pilosebaceous glands. Particles around 20-200 nm will not penetrate 
the skin but remain at the follicle opening and they can enter systemic distribution through subcutaneous 
lymphatic system.(Chen and Schluesener 2008) Respiratory system: Inhalation of airborne silver particles. 
Particles first settle on the moist outer surface of the alveoli and can reside there for up to 7 days.(Chen and 
Schluesener 2008) Gastrointestinal system: Direct consumption of elemental silver or nanoparticles in the form 
of supplements and medication. Particles may reside on the sub-mucosal region of the intestine and be absorbed 
into the lymphatic or the capillary system.(Chen and Schluesener 2008, Eckhardt, Brunetto et al. 2013) Female 
urogenital: silver impregnated sanitary napkins for prevention of odor and infections.(Brandtzaeg 1997) Brain: 
silver nanoparticles and colloidal formulations in the blood stream circulate to the blood-brain 
barriers.(Eckhardt, Brunetto et al. 2013) 
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4. Silver and its effects on human health 
Unlike copper, iron, and zinc, which are essential trace metals, silver does not naturally 
occurr in the human body. Figure 3 presents potential exposure routes allowing entry of 
silver into the body. Silver poisoning has been reported in individuals exposed to silver over 
a long period, with the severity of toxicity in general linked to the dosage.(Eckhardt, Brunetto 
et al. 2013) The toxicity of nanosilver can cause ill effects on humans as well as on the 
environment. Symptoms of silver exposure include a blueish discoloration of the skin, called 
argyria, or discoloration of the eye, called argyrosis. Exposure to soluble silver complexes can 
cause liver and/or kidney damage with the toxicity of silver affected by a number of factors, 
such as particle size, shape, surface or capping agents.(Mathur, Jha et al. 2017) 
Toxicity studies on seven-week-old male rats with three daily oral treatments of 3.6 mg/kg 
silver nanoparticles for 14 days have shown that silver nanoparticles can lead to toxic effects 
on the host and the host gut microbiome.(Javurek, Suresh et al. 2017) The exposure of 
Sprague-Dawley male rats to different shapes of silver nanoparticles (highly dispersed, 
uniform nanocubes with a diameter of 50 nm, an average size of 84 nm and nanospheres with 
an edge length of 45 nm, average size of 93 nm) showed an impact on the gut microbiota\ 
and on some rat behaviors, but induced no significant histopathological changes in the 
gastrointestinal system and brain.(Javurek, Suresh et al. 2017) The authors concluded that 
the short-term and low dose exposure (two weeks) of silver nanoparticles to male rats led to 
both behavioral changes (anxiety-like, possibly stereotypical and increased repetitive 
behavior) and to gut microbiome changes, with the latter activity due to the nanoparticle 
antimicrobial activity affecting the bacteria comprising the gut microbiome.(Javurek, Suresh 
et al. 2017) Other rat experiements have shown an effect on neurotransmitters after 
exposure to silver nanoparticles (2.25 mg/kg), accompanied by changes in noradrenaline 
and dopamine levels in the brain.(Hadrup and Lam 2014) An autoimmune condition was 
found in mouse strains after addition of 0.5 g/L of silver nitrate in the drinking 
water.(Havarinasab, Pollard et al. 2009) The oral administration of silver nanoparticles 
(12 nm in size, 300 mg/kg/d) to female rats resulted in inflammation, apoptosis and 
degenerated follicles.(Ema, Okuda et al. 2017) 
Silver may be stored, metabolized or excreted in the human body. Upon oral exposure, silver 
was deposited as particles in tissues such as the skin epidermis, glomeruli or 
intestines.(Hadrup and Lam 2014) Nanotoxicity could be induced by the unwanted 
distribution of nanoparticles to non-target tissue.(Mathur, Jha et al. 2017) In most cases of 
argyria affecting the skin, silver compounds are metabolized and silver residues are 
deposited in the skin. Ultrafine nanoparticles can normally be taken up by any organ and 
circulated throughout the body, resulting in systemic effects.(Chen and Schluesener 2008) 
Autopsies of patients who were identified as undertaking silver therapy have generally found 
that silver was not associated with their death, which was usually attributed to a progression 
of their underlying illness. For example, a 71-year-old male, taking silver combinations with 
an anti-androgen to suppress prostatic cancer, died 5.5 months after the consumption of 
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silver. His autopsy showed a brain with Alzheimer’s type 2 and an intact nervous 
system.(Lansdown 2007) In another case both a 60-year-old man and an 18-year-old man 
developed localized argyria after being exposed to silver nitrate in wound dressings. There 
were no traces of neurological or behavioral changes, nor signs of accumulation in the brain. 
The most adverse case appears to be that of a woman (age not given) who had died from an 
extreme systemic shock and circulatory failure after being given a 7% silver nitrate solution 
to induce abortion. Autopsy showed that silver was present evenly over her entire body, 
including her brain, and her tissues were extremely congested.(Lansdown 2007) 
Regardless of several reported adverse reactions, most studies have concluded that silver 
causes no direct or significant harm leading to death. It seems that systemic and localized 
argyria is the only major concern of using silver. An argyria reversing treatment has been 
developed for localized argyria pigments via treatment with a 1064 nm Q-switched Nd:YAG 
laser.(Griffith, Simmons et al. 2015) The mechanism of removal has yet to be fully 
understood, however it is believed to be somewhat similar to the removal of tattoo ink 
pigments where tattoo particles absorb the photons and photo-acoustically explode and are 
subsequently engulfed by circulating macrophage to be drained through the lymphatic 
system.(Griffith, Simmons et al. 2015) 
In order to reduce toxicity, some strategies have suggested binding silver to sulfur molecules 
or enveloping it in biological membrane. However these approaches pose a challenge as 
altered silver nanoparticles are likely to be less effective at releasing bioactive Ag+ 
ions.(Hatipoglu, Keleştemur et al. 2015) To minimize adverse effects such as allergies, rashes, 
itches, and swelling associated with the use of classical chemically synthesized particles, 
patient-friendly strategies free of “chemical” contamination have been suggested as a 
healthier option. The potential of photosynthesized silver nanoparticles for wound dressings 
were reported in an in vivo study in rats, where cotton fabrics incorporated with silver 
nanoparticles proved to increase wound healing activity compared to a silver-free 
commercial burn heal ointment named “Burn Heal” (CIPLA Ltd., India) of unknown 
content.(Pannerselvam, Jothinathan et al. 2017) Moreover, the anti-inflammatory activity of 
aqueous suspensions of silver nanoparticles was tested in animal model to alleviate colitis in 
mice as promising agents for the treatment of inflammatory bowel diseases.(Siczek, Zatorski 
et al. 2016) In another study, the hospital strain P, aeruginosa, resistant to many antibiotics, 
was sensitive to commercially available silver nanoparticles (10 nm) at concentrations of 
0.156 µg/mL, which in cytotoxicity tests were shown to be safe for mammalian cell lines at 
concentrations of up to 2.5 µg/mL.(Salomoni, Léo et al. 2017) 
As already mentioned in section 2, dental caries are treated with silver diamine fluoride 
cleared by the U.S. FDA as a medicament and commercially available in several countries 
(China, Japan, Germany, Nepal, Brazil, Argentina, New Zealand and Australia) for many 
decades.(Fung, Duangthip et al. 2017, Mei, Nudelman et al. 2017) 
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5. Silver versus other metals  
Silver is not the only metallic element that possesses antimicrobial properties. Metals with 
bactericidal properties against Gram-positive and Gram-negative bacteria include gold, 
copper, zinc, titanium, nickel, magnesium, ruthenium and others.(Grass, Rensing et al. 2011, 
Xu and Imlay 2012, Dizaj, Lotfipour et al. 2014, Vimbela, Ngo et al. 2017, Mital and Ziora 
2018) Most metals that are non-essential co-factors can cause harmful toxic effects in 
humans, even at the lowest concentration. Essential metals including chromium, copper, iron, 
magnesium, manganese, molybdenum, potassium, selenium, zinc, sodium, cobalt, lithium, 
nickel, silicon, and vanadium are metals which take part in biological processes in the human 
body such as, for example, in the regulation of cells. Essential metals must be consumed at an 
appropriate amount, too little and bodily function may suffer, while having too much will 
cause toxic side effects. An example can be seen in the human intake of zinc: when taken in 
slight excess (even by 3-10 mg) it results in copper levels in the system to drop which in turn 
leads to other complications.(Yasuyuki, Kunihiro et al. 2010) Moreover, experiments with 
mice fed with zinc for five weeks revealed dietary zinc to alter the gut microbiota, with 
increased levels resulting in intensified severity of Clostridium difficile infection.(Zackular, 
Moore et al. 2016) Other metals are classified to be completely toxic to humans, such as lead, 
tin, mercury, and tellurium.(Yasuyuki, Kunihiro et al. 2010, Lemire, Harrison et al. 2013)  
Gold is more inert to oxidation and degradation than silver and is regarded to be safer in 
human biological systems.(Boda, Broda et al. 2015) Gold is a non-essential metal that will 
only display toxicity if administered in a relatively high concentration or in complexes with 
hazardous materials. Unlike silver, which has the tendency to cause argyria and other related 
poisoning, gold is known to be far more biocompatible.(Martin, LiLow et al. 2015) Gold has 
been widely used, especially in the field of carrier selection for drug and genetic therapies. 
This is mainly due to the benefits of gold nanoparticle, which can be generated with tailored 
morphology.(Martin, LiLow et al. 2015, Vimbela, Ngo et al. 2017) Gold has also been assessed 
for its antimicrobial properties. However, the mechanism in which gold acts as an 
antimicrobial agent differs from silver. Gold nanoparticles are known to reduce cellular ATP 
by inhibiting ATPase.(Boda, Broda et al. 2015) Also, gold has been observed to prevent 
protein synthesis by inhibiting the binding of tRNA to the ribosomal subunits.(Schröfel, 
Kratošová et al. 2014, Vimbela, Ngo et al. 2017) Some killing mechanisms are common with 
silver, such as interacting with peptidoglycan and preventing its synthesis.(Tiwari, Vig et al. 
2011) In direct comparison, minimum inhibitory concentration (MIC) tests showed a higher 
activity of silver nanoparticles (MIC of 128 µg/mL for gold and 8 µg/mL for silver against 
Gram-negative bacteria E. coli, and MIC of 512 µg/mL for gold and 32 µg/mL for silver against 
Gram-positive bacteria S. aureus).(Ahmad, Wani et al. 2013) Another study demonstrated 
MIC values of cefaclor being reduced while complexed with gold nanoparticles against S. 
aureus and E. coli.(Rai, Prabhune et al. 2010) MIC values against Streptococcus mutans were 
stated as 4.9 µg/mL for silver and a higher value was found for gold 
(197 µg/mL).(Hernández-Sierra, Ruiz et al. 2008) 
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Copper is frequently used in household hardware and has long been recognized for its 
antimicrobial properties. In the agricultural sector, copper sulfate mixtures have been used 
to prevent fungal growth on agricultural produce such as grape vines, potato, peach trees, 
and apples. Even today, copper salts are widely applied as a preventive measure against 
infection outbreaks on food crops.(Lemire, Harrison et al. 2013) The over dosage of copper, 
an essential metal to the human body, has been known to cause toxic effects on the bone 
marrow and the liver. Regardless of side effects, copper can also be a versatile infection 
reducing agent with the cellular damage induced by reactions between released copper ions 
and the bacteria membrane.(Vimbela, Ngo et al. 2017) Over the years, bacteria biofilms have 
been observed to selectively avoid growing on copper surface such as copper door knobs and 
copper wires. Copper ions can also complex with bacterial nucleotides which retard repair 
mechanisms and bring cellular processes to a halt.(Martin, LiLow et al. 2015, Hoseinzadeh, 
Makhdoumi et al. 2017) The toxicity of copper nanomaterials was found to be size-dependent 
with smaller particles possessing a higher toxicity.(Vimbela, Ngo et al. 2017) Composites of 
copper and zinc loaded montmorillonites revealed a synergistic antibacterial activity against 
E. coli, and S. aureus with correlation to the specific surface area.(Jiao, Lin et al. 2017) 
Comparison of the efficacy of metals against bacteria strains P, aeruginosa, S. aureus and E. 
coli revealed copper to be more effective for the prevention of biofilm attachment, 
eradication of biofilms and prevention of planktonic cell growth than silver.(Gugala, Lemire 
et al. 2017) In this study, copper and titanium were found as the most effective metals against 
biofilm formation of all strains.(Gugala, Lemire et al. 2017) 
Zinc is well known for its antimicrobial properties as it is often used in the production of 
cosmetic and skin care products (sold as an ingredient in skin care products to minimize 
acne), both as a preservative and as an antimicrobial.(Sirelkhatim, Mahmud et al. 2015, 
Padmavathy and Vijayaraghavan 2016) In some cases, zinc is taken in oral formulated tablets 
as supplements for those who have zinc deficiencies,(Gupta, Mahajan et al. 2014) and has 
been marketed to prevent colds.(Bauer 2015) Antimicrobial action is possible regardless of 
whether it is present as zinc salts, zinc-carbomers, zinc-complexes, or zinc oxides, as long as 
it ionizes into zinc ions.(Pasquet, Chevalier et al. 2015) Similar to silver nanoparticles, when 
zinc nanoparticles release bioactive ions, they destabilize the bacterial cell membrane and 
cell wall via generation of ROS.(Padmavathy and Vijayaraghavan 2016, Saini, Saha et al. 2016, 
Patil and Kim 2017) With bulk zinc oxide approved by the FDA as a ‘generally recognized as 
safe’ (GRAS) substance, zinc oxide nanoparticles are considered as biocompatible and 
suitable candidates for chemotherapeutic agents, drug carrier systems for loading and 
transporting drugs or antimicrobial agents.(Mishra, Mishra et al. 2017) Interestingly, a 
combination of silver and zinc oxide nanoparticles revealed antibacterial activity against 
Mycobacterium tuberculosis with no cytotoxic effects on macrophages revealing superior 
properties than each of the silver or zinc oxide nanoparticles alone.(Jafari, Mosavi et al. 2016)  
Overall, the potential of metal ions as anti-microbial agents lies in their ability to supplement 
the limited existing options to fight multidrug-resistant and biofilm-related 
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infections.(Gugala, Lemire et al. 2017) The bactericidal activity of antimicrobial peptides has 
been enhanced by complexing metal-binding sites of the peptide antibiotics with transition 
metals.(Jeżowska-Bojczuk and Stokowa-Sołtys 2017) Moreover, synergistic effects against 
microbes were found for formulations of several metals mixed in combinatorial 
treatments.(Garza-Cervantes, Chávez-Reyes et al. 2017) Mixing of silver with nickel, 
cadmium, copper increased their antimicrobial activity significantly against E. coli while 
mixing with copper, zinc, cobalt enhanced the activity against B. subtilis. One explanation for 
the observed synergy relies on the increased cell permeability of these formulations.(Garza-
Cervantes, Chávez-Reyes et al. 2017) 
6. Synergistic effects of silver nanoparticles and antibiotics 
In the search for solutions to overcome bacterial drug resistance(Butler, Blaskovich et al. 2016, 
Crofts, Gasparrini et al. 2017), one option is the combination of antibiotics with antibacterial 
metals such as silver(Nagy, Harrison et al. 2011), copper or gold. Studies combining silver 
nanoparticles with ‘defeated’ antibiotics have been initiated over the last ten years, with 
results successfully showing that silver can revitalize antibiotics to treat resistant bacteria.  
However, because the mode of action of antibiotics is diverse, with, some targeting the 
microbe cell wall synthesis and others affecting DNA/RNA or protein synthesis, synergistic 
effects aren’t observed in all complexes. The first evidence that vancomycin, normally only a 
Gram-positive antibiotic, could also act on Gram-negative bacteria was found for its 
combinations with silver, not only enhancing the activity against bacteria but also offering a 
new mode of action.(Morones-Ramirez, Winkler et al. 2013) 
Other approaches involving the combination of different antibacterial agents with either 
silver nanoparticles or silver nitrate have been reported in recent years. For example, the 
combination of silver nanoparticles and visible blue light was reported to enhance 
antimicrobial activity.(Akram, El-Tayeb et al. 2016, El Din, El-Tayeb et al. 2016) A triple 
combination of silver nanoparticles, blue light and antibiotics (amoxicillin or vancomycin) 
resulted in synergistic effects especially against methicillin resistant S. aureus (MRSA) 
isolates.(Akram, El-Tayeb et al. 2016) Improvement in activity of up to three orders of 
magnitude were reported for the combination of methylene blue and silver nitrate compared 
to the antibacterial agent alone,   against a range of species (Enterobacter cloacae, 
K. pneumoniae, P, aeruginosa, E. coli and Serratia marcescens).(Li, Chen et al. 2016)  
Table 3 presents various combinations of antibiotics with different forms of silver, with the 
antibiotics classified according to their structural class. 
 
6.1. β-Lactam antibiotics and silver nanoparticles 
The β-lactams in Table 3 are divided in penicillin, cephalosporin, and carbapenem subclasses 
incorporating the most successful and widely used antibiotics, yet those most threatened by 
resistance. The lactam antibiotics work by binding irreversibly to DD-transpeptidases that 
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facilitate the final crucial step of transpeptidation during peptidoglycan synthesis. Inhibition 
prevents interlinking between the subunits of the peptidoglycan layer and thus stops cell wall 
synthesis.(Fisher, Meroueh et al. 2005) 
Resistance against β-lactam antibiotics emerged shortly after they were commercially 
launched in 1945.(Brown, Butterworth et al. 1976) One of the most common resistance 
mechanisms of bacteria involves the production of β-lactamases. These enzymes break down 
the β-lactam ring of the antibiotic that is crucial for its activity. Combining a β-lactam 
antibiotic such as amoxicillin with a β-lactamase inhibitor such as clavulanic acid can 
abrogate this resistance.(Leonard, Bonomo et al. 2013) Another resistance method is through 
the bacteria’s alterations of DD-transpeptidases, observed in MRSA and penicillin-resistant 
Streptococcus pneumoniae.(Utsui and Yokota 1985) Methylation or glycosylation prevents 
the antibiotic from binding effectively to its binding site. The two resistance mechanisms 
mentioned above can be countered by simply linking β-lactam antibiotics to silver 
nanoparticles.  
Increased activity could be observed for some complexes, with either additive or synergistic 
effects. It is difficult to compare results presented in the literature from different studies as 
authors report the observed interaction in a variety of ways, using different types of assays 
(e.g. broth microdilution vs agar zone of inhibition) against different bacterial strains. The 
results can be described as % increase, percentage, or FICI (Fractional Inhibitory 
Concentration)(Möhler, Kolmar et al. 2017), which cannot be directly compared. Keeping in 
mind that the difference in nanoparticles size and morphology can also affects the final 
activity, it is difficult to analyze the findings other than to present them. 
The % increase was either obtained from the presented publications or calculated with data 
presented in the respective article. The equation was % increase = (x-y)/y where x is the 
inhibition zone for the antibiotic in combination with silver nanoparticles and y is the 
antibiotic alone. FICI values were calculated with the following equation (FICI values ≤0.5 
indicate synergistic effects): 
𝐹𝐼𝐶𝐼 =  
𝑀𝐼𝐶𝑎𝑛𝑡𝑖𝑏𝑖𝑜𝑡𝑖𝑐 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛
𝑀𝐼𝐶𝑎𝑛𝑡𝑖𝑏𝑖𝑜𝑡𝑖𝑐 𝑎𝑙𝑜𝑛𝑒
+  
𝑀𝐼𝐶𝑠𝑖𝑙𝑣𝑒𝑟 𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛
𝑀𝐼𝐶𝑠𝑖𝑙𝑣𝑒𝑟 𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑎𝑙𝑜𝑛𝑒
 
The activity of ampicillin, penicillin and amoxicillin was enhanced against a broad range of 
strains as summarized in Table 3. Strong synergistic effects were observed in combination 
with silver nanoparticles at concentrations of 2.5 mg/mL accompanied with no cytotoxic 
effect on mammalian cells.(Panáček, Smékalová et al. 2015) in the size of 28 nm against E. 
coli, S. aureus, P, aeruginosa showing a decreased MIC against the tested bacteria. Silver 
nanoparticles added to penicillin resulted in a four-fold increase in activity against penicillin-
resistant S. pneumonia, (Ghosh, Patil et al. 2011) though another study reported a much more 
moderate 12% increase in killing methicillin-resistant S. aureus by adding silver 
nanoparticles to methicillin (Devi and Joshi 2012). 
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Penicillin, ampicillin and feropenem combined with silver nanoparticles exhibited a 
significant increased activity against the bacteria strain K. pneumoniae.(Ghosh, Patil et al. 
2011) The combination of nanocomposites of silver, titanium-nanotubes and penicillin were 
synergistic against E. coli (FICI of 0.38).(Xu, Cheng et al. 2017) Ampicillin with silver 
nanoparticles showed synergistic effects against five bacteria strains with FICI values 
ranging from 0.38 to 0.5.(Hwang, Hwang et al. 2012) Silver nanoparticles synthesized 
through a bacteria assisted procedure (with S. xinghaiensis OF1 strain) combined with 
ampicillin were synergistic against E. coli, K. pneumoniae, S. aureus and B. subtilis (FICI of 
0.12).(Wypij, Czarnecka et al. 2018) Another significant improvement was observed for 
piperacillin complexed with silver nanoparticles against A. baumannii and 
P, koreensis.(Ghosh, Patil et al. 2011) Silver nanoparticles resulted in more potent agents 
against S. aureus when combined with penicillin (MIC: 0.06 µg L-1)(Panáček, Smékalová et al. 
2015) and oxacillin (MIC: 0.48 µg L-1)(Panáček, Smékalová et al. 2015), and against E. coli 
with ampicillin.(Hwang, Hwang et al. 2012, Panáček, Smékalová et al. 2015) Synergistic 
activity with cefazolin and cephalothin was dependent on the size of the nanoparticle (Hari, 
Thomas et al. 2014) The performance of cefotaxime and ceftazidime was also improved when 
complexed with silver nanoparticles, with synergistic effects reported against E. coli, K. 
pneumoniae and P, aeruginosa.(Gurunathan 2015, Panáček, Smékalová et al. 2015, Panáček, 
Smékalová et al. 2016) Complexes with meropenem even showed an increased activity 
against resistant bacteria compared to susceptible strains.(Panáček, Smékalová et al. 2016) 
6.2. Aminoglycoside, glycopeptide and ansamycine class antibiotics and silver 
nanoparticles 
The aminoglycoside streptomycin was first developed in 1944, followed by others with 
similar chemical structure. In contrast to β-lactam antibiotics, aminoglycosides are highly 
effective against Gram-negative bacteria.(Mingeot-Leclercq, Glupczynski et al. 1999) They 
are classified as protein synthesis inhibitors which kill bacteria by binding irreversibly to the 
30S subunit of the ribosomal decoding site. This action leads to an inaccurate mRNA 
translation and immature protein formation. Immature cell membrane proteins cause 
changes in cell permeability.(Hermann 2007) There are two known mechanisms by which 
bacteria gain resistance to aminoglycoside antibiotics. Genetic alterations lead to changes in 
membrane proteins which result in a lower permeability to surrounding metabolites. The 
second mechanism of resistance proceeds via production of aminoglycoside-modifying 
enzymes which covalently modify amino- and hydroxyl-functions on the aminoglycoside 
antibiotic. This reduces the binding affinity of the drug and prevents it from inhibiting the 
bacteria’s ribosome. Enterobacteriaceae bacteria are commonly known to possess the gene 
causing this modification.(Mingeot-Leclercq, Glupczynski et al. 1999)  
A number of studies have reported increased activities for aminoglycoside antibiotics 
complexed with silver nanoparticles against over fifteen strains, with synergistic increases 
reported for at least five of these (Table 3). Streptomycin, kanamycin and gentamicin 
complexes performed with comparable activity against B. subtilis, E. coli, S. aureus and K. 
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pneumoniae with enhancements ranging from 5% to 25%.(Baker, Pasha et al. 2015) Other 
studies with divergent synthesis methods for the nanoparticles reporting increases in 
activity of up to 57% for gentamicin against S. aureus.(Dhas, Mukherjee et al. 2013, 
Manikprabhu and Lingappa 2013) When directly compared, streptomycin exhibited the 
greatest improvement in activity against E. coli strains, kanamycin against P, aeruginosa and 
amikacin with a moderate increase compared to the two others but with a broad spectrum 
of activity.(Ghosh, Patil et al. 2011) For other studies FICI values were calculated for silver 
complexes of kanamycin(Hwang, Hwang et al. 2012) and gentamicin,(Smekalova, Aragon et 
al. 2016, Wang, Tang et al. 2016) with both antibiotics being similarly active against S. aureus 
and E. coli. Kanamycin combined with silver nanoparticles exhibited synergistic effects 
against E. coli, K. pneumoniae, S. aureus and B. subtilis (FICI of 0.12).(Wypij, Czarnecka et al. 
2018) Gentamicin combined with nanocomposites of silver and titanium-nanotubes 
produced synergistic effects against S. aureus (FICI of 0.33) and MRSA (FICI of 0.15)(Xu, 
Cheng et al. 2017), or with silver nanoparticles synthesized by reduction of AgNO3 in the 
presence of histidine and against K. pneumoniae (FICI of 0.15).(Kumar, Bansal et al. 2018) 
Within this study, histidine was found the most potent amino acid for combinations of amino 
acid-capped silver nanoparticles and different antibiotics with MIC values up to 0.9 mg/mL 
against K. pneumoniae and P, aeruginosa, 1.8 mg/mL against E. coli and S. aureus, and action 
against drug resistant clinical strains (K. pneumoniae, S. epidermidis, S. aureus).(Kumar, 
Bansal et al. 2018) 
6.3. Chloramphenicol, macrolide and tetracycline antibiotics and silver nanoparticles 
Chloramphenicol antibiotics were commercialized in the year 1949, originally isolated from 
S. venezuelae strains.(Smadel, Woodward et al. 1949) Similar to aminoglycosides, these 
antibiotics function by inhibiting protein synthesis, but they bind to the 50S ribosomal 
subunit, not the 30S. The mechanism of chloramphenicol is similar to macrolides in binding 
to the 50S ribosome.(Joseph, Al-Hakami et al. 2015) However, chloramphenicol prevents the 
proper binding of ribosomal substrates whereas the macrolides prevent elongation of the 
peptide strand.(Wolfe and Hahn 1965) 
One resistance mechanism that bacteria have developed against chloramphenicol and 
macrolide antibiotics is to alter the 50S ribosomal subunit.(Tenson, Lovmar et al. 2003) 
Bacteria can also adapt by reducing membrane permeability. For chloramphenicol, bacteria 
can also produce chloramphenicol acetyltransferase which covalently inactivates 
chloramphenicol molecules.(Miyamura, Ochiai et al. 1977) 
The combination of chloramphenicol and silver nanoparticles showed synergistic effects 
against E. faecium, S. mutans, E. coli and P, aeruginosa.(Hwang, Hwang et al. 2012) 
Furthermore, an increased activity was observed against S. aureus, K. pneumoniae and other 
bacteria strains.(Hari, Thomas et al. 2014) The increases were rather small (around 20%) 
compared to the values reported for β-lactam or aminoglycoside antibiotics. The highest 
increase was observed against P, aeruginosa.(Ghosh, Patil et al. 2011) Erythromycin showed 
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an improved action against eight bacteria strains with a maximum of 100% inhibition against 
A. baumannii.(Ghosh, Patil et al. 2011) 
The activity of tetracycline against E. coli, K. pneumoniae, S. aureus and B. subtilis was 
enhanced with silver nanoparticles synthesized by S. xinghaiensis.(Wypij, Czarnecka et al. 
2018) Furthermore, the activity of both vancomycin and rifampicin was improved against 
methicillin resistant S. aureus (FICI of 0.38 and 0.25, respectively) when combined with 
silver-loaded nanotubes.(Xu, Cheng et al. 2017) Thioglycolic acid-stabilized silver 
nanoparticles functionalized with vancomycin on the terminal carboxyl of thioglycolic acid 
exerted antimicrobial activity against methicillin resistant S. aureus (MIC of 0.05 µg/mL), 
vancomycin resistant E. faecalis (MIC of 0.1 µg/mL) and S. epidermidis (MIC below 
0.02 µg/mL).(Esmaeillou, Zarrini et al. 2017) 
Other antibiotic classes that have been combined with silver nanoparticles include the 
fluoroquinolone ciprofloxacin, which showed synergistic effects against multi-resistant β-
lactamase and carbapenemase producing Enterobacteriaceae.(Panáček, Smékalová et al. 
2016) Combining other antibacterial quinolones (compounds based on a 4-oxo-1,4-
dihydroquinolone skeleton) with silver complexes also revealed increased antibacterial and 
antifungal properties.(Rusu, Hancu et al. 2017) 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Table 3: Overview of complexes between antibiotics and silver nanoparticles, synergistic effects against 
specific bacteria strains, silver nanoparticle (AgNP) synthesis and the size/morphology. 
Antibiotic  AgNP synthesis method AgNP size [nm]/ 
morphology / 
concentration [µg mL-1] 
Bac. Strains tested – activity observed Ref. 
 
Penicillin Plant-Assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / mostly spherical, 
nanorods, triangular / 
30 µg per disc 
A. baumannii – 86; E. cloacae – 71; K. 
pneumoniae – 128; N. mucosa – 4; P. 
aeruginosa – 86; S. typhi – 33; B. subtilis – 
57; P. koreensis – 57 
*% increase  
(Ghosh, Patil 
et al. 2011) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
26 / spherical / 0.6 S. aureus – synergistic effects (0.6 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Chemical: [Ag(NH3)2]+ by D-
maltose 
8 / spherical / 6.3 A. pleuropneumoniae – 0.3 
*FICI 
(Smekalova, 
Aragon et al. 
2016) 
Reduction of AgNO3 on 
unannealed TiO2 nanotubes by 
irradiation with UV light 
20-40 / spherical / 0.125-
0.5 
E. coli – 0.5 (partial synergistic); S. aureus – 
0.516 (partial synergistic); MRSA – 0.5 
*FICI 
(Xu, Cheng et 
al. 2017) 
Ampicillin Dissolving and precipitation of 
solid silver. 
3 / spherical / 2-8 E. faecium – 0.38; S. aureus – 0.5; S. mutans 
– 0.38; E. coli – 0.5; P. aeruginosa – 0.5 
*FICI 
(Hwang, 
Hwang et al. 
2012) 
Fungi-Assisted: T. viride provided 
with AgNO3 precursor. 
5-30 / spherical / 10µg per 
disk 
E. coli – 75; S. typhi – 82; S. aureus – 73; M. 
luteus – 70 
*% increase 
(Fayaz, Balaji 
et al. 2010) 
Plant-Assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
A. baumannii – 71; K. pneumoniae – 114; N. 
mucosa – 127; P. aeruginosa – 100; S. typhi 
– 35; V. parahaemolyticus – 8; B. subtilis – 
70; P. koreensis – 18; S. aureus – 6 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 E. coli – synergistic effect showed by MIC of 
0.03 mg/L 
*presented MIC values  
(Panáček, 
Smékalová et 
al. 2015) 
Bacteria-assisted: S. xinghaiensis 
with AgNO3 precursor. 
5-20 / spherical and 
polydispersed / 0.004-0.12 
E. coli; K. pneumoniae, S. aureus, B. subtilis – 
0.12 
*FICI 
(Wypij, 
Czarnecka et 
al. 2018) 
Amoxicillin Chemical: [Ag(NH3)2]+ by D-
maltose 
28 / spherical / 12.5 A. pleuropneumoniae – 0.4 
*FICI 
(Smekalova, 
Aragon et al. 
2016) 
Plant-Assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
A. baumannii – 29; E. cloacae – 14; K. 
pneumoniae – 20; P. aeruginosa – 71; S. 
typhi – 71; P. koreensis – 43; S. aureus – 43 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Oxacillin 
 
Bacteria-assisted: S. coelicolor 
provided with AgNO3 precursor.  
28-50 / Irregular shaped / 
10 
S. aureus – 100 
*% increase 
(Manikprabh
u and 
Lingappa 
2013) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 1.25 S. aureus -  synergistic effects (0.03 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Piperacillin 
 
Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
A. baumannii – 114; S. typhi – 20; B. subtilis 
– 40; P. koreensis – 114 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 P. aeruginosa – synergistic effects 
(0.015 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Cefazolin 
 
1) Plant-assisted: AgNO3 reduced 
with A. sativum extract. 2) 
Chemical: AgNO3 reduction with 
sodium citrate. 
1) 14 /spherical / 20; 2) 12 
/ spherical / 20 
L. lactis – 14; M. luteus – 30; E. coli – 3.4; P. 
aeruginosa – 15; L. lactis – 7; M. luteus – 10; 
P. vulgaris – 3.2 
*% increase 
(Hari, 
Thomas et al. 
2014) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 E. coli – synergistic effects (0.0019 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Ceftriaxone 
 
Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular/ 30 µg per disc 
H. influenza – 15; S. typhi – 20; V. 
parahaemolyticus – 20 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Cefotaxime 
 
Plant-assisted: AgNO3 reduced 
with T. angustifolia leave extract. 
8 / spherical / 1.4 E. coli – 63; K. pneumonia – 63 
*% increase 
(Gurunathan 
2015) 
Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
A. baumannii – 30; H. influenza – 21; S. 
typhi – 11; V. parahaemolyticus – 13; B. 
subtilis – 7 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Tollens-process: Reduction of 
AgNO3 with NaOH and D-maltose, 
stabilized by gelatin (0.05%) 
28 nm / spherical / 0.4-3.4 ESBL-positive E. coli – 0.4; AmpC-positive 
E. coli – 0.28; ESBL-positive K. pneumoniae 
– 0.18 
*FICI 
(Panáček, 
Smékalová et 
al. 2016) 
Cefuroxime Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 E. coli – synergistic effects (0.00097 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Cefoxitin Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 E. coli – synergistic effects (0.00097 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Cefepime Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 P. aeruginosa – synergistic effects 
(0.00024 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Cefoperazone Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 P. aeruginosa – synergistic effects 
(0.00024 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Ceftazidime 
 
Plant-assisted: g+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
E. coli – 100; S. odorifera – 4; P. koreensis – 
6; S. aureus – 25 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Chemical: [Ag(NH3)2]+ by D-
maltose 
28 / spherical / 2.5 P. aeruginosa – synergistic effects 
(0.00024 mg/L) 
 *MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Tollens-process: Reduction of 
AgNO3 with NaOH and D-maltose, 
stabilized by gelatin (0.05%) 
28 nm / spherical / 0.4-3.4 ESBL-positive E. coli – 0.36; AmpC-positive 
E. coli – 0.28; KPC-positive K. pneumoniae – 
0.38; ESBL-positive K. pneumoniae – 0.2 
*FICI 
(Panáček, 
Smékalová et 
al. 2016) 
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Cephalothin 
 
1) Plant-assisted: AgNO3 reduced 
with A. sativum extract. 2) 
Chemical: AgNO3 reduction with 
sodium citrate. 
1) 14 /spherical / 20; 2) 12 
/ spherical / 20 
1) S. aureus – 9; M. luteus – 18; B. subtilis – 
30; P. mirabilis – 5.8. 2) P. aeruginosa - 7.1; 
L. lactis - 7.1; B. subtilis - 30; S. typhi - 7.6; P. 
mirabilis -2.9  
*% increase 
(Hari, 
Thomas et al. 
2014) 
Meropenem Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
K. pneumoniae – 114; P. koreensis – 5 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Tollens-process: Reduction of 
AgNO3 with NaOH and D-maltose, 
stabilized by gelatin (0.05%) 
28 nm / spherical / 0.4-3.4 
 
KPC-positive K. pneumoniae – 0.37 
*FICI 
(Panáček, 
Smékalová et 
al. 2016) 
 
Strepto- 
mycin 
Bacteria-assisted: P. veronii 
provided with AgNO3 and HAuCl4 
precursor. 
30 /mixture / 1 B. subtilis – 3.8; E. coli – 20; S. aureus – 9.5; 
K. pneumoniae – 7.1 
*% increase  
(Baker, Pasha 
et al. 2015) 
Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
E. coli – 257; P. aeruginosa – 33; S. typhi – 
43 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Neomycin Chemical: AgNO3 reduced with 
sodium citrate. 
23 / / 5 S. typhimurium – not quantified, but noted 
synergistic increase.  
(McShan, 
Zhang et al. 
2015) 
Kanamycin Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
A. baumannii – 42; E. coli – 14; K. 
pneumoniae – 29; P. aeruginosa – 129; S. 
typhi – 43; V. parahaemolyticus – 5; P. 
koreensis – 10; S. aureus – 6 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Fungi-Assisted: T. viride provided 
with AgNO3 precursor. 
5-30 / spherical / 10 µg per 
disk 
E. coli – 33; S. typhi – 46; S. aureus – 22; M. 
luteus – 10 
*% increase 
(Fayaz, Balaji 
et al. 2010) 
Dissolving and precipitation of 
solid silver. 
3 / spherical / 2-4 E. faecium – 0.75; S. aureus – 0.38; S. 
mutans – 0.38; E. coli – 0.5; P. aeruginosa – 
0.38 
*FICI 
(Hwang, 
Hwang et al. 
2012) 
Bacteria-assisted: P. veronii 
provided with AgNO3 and HAuCl4 
precursor. 
30 / mixture / 1 B. subtilis – 12; E. coli – 12; S. aureus – 8.6; 
K. pneumoniae – 25 
*% increase 
(Baker, Pasha 
et al. 2015) 
Bacteria-assisted: S. xinghaiensis 
with AgNO3 precursor. 
5-20 / spherical and 
polydispersed / 0.125-32 
E. coli; K. pneumoniae, S. aureus, B. subtilis – 
0.12 
*FICI 
(Wypij, 
Czarnecka et 
al. 2018) 
Amikacin  Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
8-20 / spherical, nanorods, 
triangular / 30 µg per disc 
E. cloacae – 5; E. coli – 80; N. mucosa – 30; 
P. aeruginosa – 57; S. typhi – 14; P. 
koreensis – 33; S. aureus – 27 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 P. aeruginosa – synergistic effects 
(0.00048 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
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Gentamicin  
 
Bacteria-assisted: P. veronii 
provided with AgNO3 and HAuCl4 
precursor. 
30 / mixture /1 B. subtilis – 3.1; E. coli – 15; S. aureus – 4; K. 
pneumonae – 22 
*% increase 
(Baker, Pasha 
et al. 2015) 
Bacteria-assisted: S. coelicolor 
provided with AgNO3 precursor.  
28-50 / Irregular shaped / 1 S. aureus – 57 
*% increase 
(Manikprabh
u and 
Lingappa 
2013) 
Plant-assisted: AgNO3 reduced 
with R. apiculata extract.  
6-15 / Spherical / 30 µg per 
disk 
B. cereus – 25; S. aureus – 44; P. mirabilis – 
11; E. coli – 14 
*% increase 
(Dhas, 
Mukherjee et 
al. 2013) 
PVP coated silver NP 37-39 / spherical E. coli – 0.37; S. aureus – 0.28 
*FICI 
(Wang, Tang 
et al. 2016) 
Chemical: [Ag(NH3)2]+ by D-
maltose 
28 / spherical / 3 - 25 E. coli – 0.4; S. aureus – 0.4; A. 
pleuropneumoniae – 0.5 
*FICI 
(Smekalova, 
Aragon et al. 
2016) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 1.25 E. coli – synergistic effects (0.06 mg/L); S. 
aureus – synergistic effects (0.015 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Reduction of AgNO3 on 
unannealed TiO2 nanotubes by 
irradiation with UV light 
20-40 / spherical / 0.125-
0.25 
S. aureus – 0.325 (partial synergistic); 
MRSA – 0.15 
*FICI 
(Xu, Cheng et 
al. 2017) 
Tollens-process: Reduction of 
AgNO3 with NaOH and D-maltose, 
stabilized by gelatin (0.05%) 
28 nm / spherical / 0.4-3.4 ESBL-positive E. coli – 0.5; AmpC-positive 
E. coli – 0.48; ESBL-positive K. pneumoniae 
– 0.33 
*FICI 
(Panáček, 
Smékalová et 
al. 2016) 
Reduction of AgNO3 by aqueous 
solution of histidine 
8-45 / spherical / 0.05 K. pneumoniae – 0.152 
*FICI 
(Kumar, 
Bansal et al. 
2018) 
Erythro- 
mycin 
Bacteria-assisted: P. veronii 
provided with AgNo3 and HAuCl4 
precursor.  
~30 / mixture / 1 B. subtilis – 8.8; E. coli – 8; S. aureus - 6.3; K. 
pneumoniae - 16 
*% increase 
(Baker, Pasha 
et al. 2015) 
Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
~8-20 / anisotropic but 
mostly spherical, nanorods 
and triangular / 30 µg per 
disc 
A. baumannii – 100; E. cloacae – 14; E. coli – 
14; K. pneumoniae – 57; N. mucosa – 8; P. 
mirabilis – 57 
*% increase 
(Ghosh, Patil 
et al. 2011) 
 
Tetracycline Bacteria-assisted: S. xinghaiensis 
with AgNO3 precursor. 
5-20 / spherical and 
polydispersed / 0.008-16 
E. coli; K. pneumoniae, S. aureus, B. subtilis – 
0.12 
*FICI 
(Wypij, 
Czarnecka et 
al. 2018) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 0.6-5 S. aureus – synergistic effects 
(0.015 mg/L); E. coli – synergistic effects 
(0.00048 mg/L)                                         *MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Chloramph-
enicol 
Bacteria-assisted: P. veronii 
provided with AgNo3 and HAuCl4 
precursor.  
~30 / mixture / 1 B. subtilis - 3.3; E. coli - 6.6; S. aureus – 16; 
K. pneumoniae – 12 
*% increase 
(Baker, Pasha 
et al. 2015) 
Dissolving and precipitation of 
solid silver.  
~3 / spherical / 1-4 E. faecium – 0.34; S. aureus – 0.75; S. 
mutans – 0.38; E.coli – 0.5; P. aeruginosa - 
0.38                                                           *FICI 
(Hwang, 
Hwang et al. 
2012) 
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1) Plant-assisted: AgNO3 reduced 
with A. sativum extract. 2) 
Chemical: AgNO3 reduction with 
sodium citrate.  
1) 14 / spherical / 20,2) 12 
/ spherical / 20 
E.coli – 28; P. aeruginosa – 16; S. aureus – 
3.5; L. lactis – 20; M. luteus – 11; B. subtilis – 
25; P. vulgaris – 3.3 
* % increase 
(Hari, 
Thomas et al. 
2014) 
 
Fungi-assisted: T. viride provided 
with AgNO3 precursor.  
~5-30 / spherical / 
10 µg per disk 
E.coli – 27; S. typhi – 24; S. aureus – 11; M. 
luteus - 10 
*% increase 
(Fayaz, Balaji 
et al. 2010) 
 
Plant-assisted: Ag+ reduced with 
D. bulbifera tuber extract. 
~8-20 / anisotropic but 
mostly spherical, nanorods 
and triangular / 30 µg per 
disc 
K. pneumoniae – 71; P. aeruginosa – 142; S. 
thypi – 9; B. subtilis – 33; S. aureus – 43 
*% increase 
(Ghosh, Patil 
et al. 2011) 
Plant-assisted: AgNO3 reduced 
with R. apiculata leave extract.  
~15 / spherical.  B. cereus – 23; S. aureus – 19; P. mirabilis - 
7.7; E. coli - 11 
*% increase 
(Dhas, 
Mukherjee et 
al. 2013) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 2.5 S. aureus – synergistic effects 
(0.00024 mg/L) 
*MIC 
(Panáček, 
Smékalová et 
al. 2015) 
Ciprofloxacin Tollens-process: Reduction of 
AgNO3 with NaOH and D-maltose, 
stabilized by gelatin (0.05%) 
28 nm / spherical / 0.4-3.4 ESBL-positive E. coli – 0.22; AmpC-positive 
E. coli – 0.34; KPC-positive K. pneumoniae – 
0.38; ESBL-positive K. pneumoniae – 0.33 
*FICI 
(Panáček, 
Smékalová et 
al. 2016) 
 
Vancomycin Reduction of AgNO3 on 
unannealed TiO2 nanotubes by 
irradiation with UV light 
20-40 / spherical / 0.125-
0.25 
S. aureus – 0.5 (partial synergistic); MRSA – 
0.375 
*FICI 
(Xu, Cheng et 
al. 2017) 
Tollens process: Reduction of 
[Ag(NH3)2]+ by D-maltose 
28 / spherical / 1.25 S. aureus – 0.25 
*FICI calculated with given MICs 
(Panáček, 
Smékalová et 
al. 2015) 
Rifampicin Reduction of AgNO3 on 
unannealed TiO2 nanotubes by 
irradiation with UV light 
20-40 / spherical / 0.125 MRSA – 0.25 
*FICI 
(Xu, Cheng et 
al. 2017) 
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7. Synergistic effects between silver nanoparticles and other compounds 
There are also silver complexes exerting synergistic effects on bacteria. Silver-N-heterocyclic 
carbene complexes showed an inhibition of bacterial growth (S. aureus, S. enterica).(Aher, 
Das et al. 2017) Silver nanoparticles synthesized and stabilized by metabolites of T. viride 
were potent against S. aureus due to an increased production of reactive oxygen 
species.(Kumari, Shukla et al. 2017) Binary silver(I) complexes with either nicotinamide or 
glycine showed a growth inhibition effect (higher in case of silver nicotinamide) and an 
increased antimicrobial activity against S. aureus and E. coli.(Rendošová, Vargova et al. 2017) 
Using titanium dioxide and silver composites, a high bacteriostatic rate against E. coli(Wang, 
Chen et al. 2017, Ye, Cheng et al. 2017) and S. aureus(Ye, Cheng et al. 2017) was achieved 
again exploiting synergistic effects of reactive oxygen species and released silver ions.(Ye, 
Cheng et al. 2017) Combination of polycationic polymers and silver cations revealed an 
antimicrobial material with activity against E. coli and S. aureus.(Guo, Xu et al. 2017) 
The combination of two or more components with synergistic effects is not necessarily 
always the best solution, as microbes can still develop resistance over a long exposure 
period.(Graves, Thomas et al. 2017) An alternative approach is to combine various 
components demonstrating antagonistic effects, especially with one of the antimicrobial 
agents being an essential metal, for example combinations of iron and silver. Bacterial 
response is developing their resistance to toxic silver by eliminating it, which consequently 
leads to reducing the iron level in the cell.  If the element is required by bacteria, but is 
eliminated by a resistance mechanism, the bacteria will facilitate their own death.(Graves, 
Thomas et al. 2017) Such reflection highlights the importance of understanding the biology 
behind the inhibition mechanisms and microbes’ behavior, their enormous potential to 
quickly adapt in new environment by activating silent genes from their rich repertoire.  
8. Remarks, perspective and prognosis 
There are now an increasing number of reports regarding the use of silver against multi-drug 
resistance bacteria that cover investigations into its mode of action, proposed mechanisms 
of antibiotic-resistance and the potential synergistic effects of complexes with antibiotics. 
Silver, when used in conjunction with antibiotics, often improves antimicrobial activity and 
can ‘resuscitate’ older antibiotics that are no longer efficacious due to the development of 
resistance.  
However, as bacterial resistance against silver nanoparticles has recently been 
described(Panáček, Kvítek et al. 2018), there is a danger that this may spread as a result of 
the increased quantity of commercially available products incorporating silver 
nanoparticles.(Gunawan, Marquis et al. 2017) Indeed, nanoparticles have been already 
detected in animal products consumed by humans.(Gallocchio, Biancotto et al. 2017) This 
resistance may be avoided by formulating the nanoparticles with antimicrobial agents that 
have synergistic effects, to reduce the chance of a stochastic response by microbes evolving 
a single mechanism of resistance.(Graves, Thomas et al. 2017, Reshma, Syama et al. 2017) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Using combinations of silver and antibiotics could re-invigorate current drugs that have lost 
their effectiveness due to the development of resistant microbes. If such combinations are 
approved, it will be prudent to control and monitor usage of silver nanoparticles, both in the 
prescription of therapeutics in a clinical setting and everyday health supplements and 
consumer products.  
Silver and silver ions cannot be treated as a ‘cure-all’ or ‘stand-alone‘ therapies, but silver 
coupled with antimicrobial agents warrant re-examination as potential investigational drug 
candidates. While silver has been shown to be cytotoxic to mammalian cells in some cases, 
recent research in orthopedic implants suggests silver nanoparticles as promising candidates 
for rational therapy design and prevention option for bacterial bone and infections.(Aurore, 
Caldana et al. 2018) Silver has been used in alternative health supplements with no 
significant adverse clinical findings at low doses(Mathur, Jha et al. 2017).  
The wider commercial availability of antimicrobial silver products necessitates better 
controls, vigilance and monitoring of clinical and environmental contamination of a potent 
antimicrobial agent. Overuse and misuse of antibiotics expedites the development of 
resistant superbugs. Future alternative treatments may include targeted therapies that 
incorporate synergistic incorporation of silver. With a paucity of new antibiotics in the 
development pipeline and even fewer truly novel chemotypes being discovered in the last 
decade, we should also explore combining ‘ineffective’ antibiotics with adjuvants, such as 
silver, to create antibiotic-metal combinations that address the dire global threat of drug-
resistant infections.  
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